Turkish Gastroenterology Association, Pancreas Study
Group, Chronic Pancreatitis Committee Consensus Report

1. van der Heijde D, Aletaha D, Carmona L, et al. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Ann Rheum Dis 2015; 74: 8-13. [Crossref]
2. Oxford Center for Evidence-Based Medicine. In: www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.
3. Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology 2016; 16: 218-24. [Crossref]
4. Sarles H, Adler G, Dani R, et al. The pancreatitis classification of Marseilles, Rome 1988. Scand J Gastroenterol 1989; 24: 641-2. [Crossref]
5. Singer MV, Gyr K, Sarles H. Revised classification of pancreatitis. Report of the Second International Symposium on the Classification of Pancreatitis in Marseille, France, March 28-30, 1984. Gastroenterology 1985; 89: 683-5. [Crossref]
6. Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984; 25: 756-9. [Crossref]
7. Nikkola J, Rinta-Kiikka I, Räty S, et al. Pancreatic morphological changes in long-term follow-up after initial episode of acute alcoholic pancreatitis. J Gastrointest Surg 2014; 18: 164-70. [Crossref]
8. Whitcomb DC, Shimosegawa T, Chari ST, et al. International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, American Pancreatic Association, Japan Pancreas Society, PancreasFest Working Group and European Pancreatic Club. Pancreatology 2018; 18: 516-27. [Crossref]
9. Yadav DI, Timmons L, Benson JT, Dierkhising RA, Chari ST. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol 2011; 106: 2192-9. [Crossref]
10. Otsuki M. Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems. J Gastroenterol 2003; 38: 315-26. [Crossref]
11. Tinto AI, Lloyd DA, Kang JY, et al. Acute and chronic pancreatitis - diseases on the rise: a study of hospital admissions in England 1989⁄90-1999⁄2000. Aliment Pharmacol Ther 2002; 16: 2097-105. [Crossref]
12. Mayerle J, Hoffmeister A, Werner J, Witt H, Lerch MM, Mössner J. Chronic pancreatitis-definition, etiology, investigation and treatment. Dtsch Arztebl Int 2013; 110: 387-93. [Crossref]
13. Kadaj-Lipka R, Lipiński M, Adrych K, et al. Diagnostic and therapeutic recommendations for chronic pancreatitis. Recommendations of the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club. Prz Gastroenterol 2018; 13: 167-81. [Crossref]
14. Spanier BW, Dijkgraaf MG, Bruno MJ. Trends and forecasts of hospital admissions for acute and chronic pancreatitis in the Netherlands. Eur J Gastroenterol Hepatol 2008; 20: 653-8. [Crossref]
15. Romagnuolo J, Talluri J, Kennard E, et al. Clinical Profile, Etiology, and Treatment of Chronic Pancreatitis in North American Women: Analysis of a Large Multicenter Cohort. Pancreas 2016; 45: 934-40. [Crossref]
16. Whitcomb DC, Yadav D, Adam S, et al. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: The North American Pancreatitis Study 2 (NAPS2). Pancreatology 2008; 8: 520-31. [Crossref]*
17. Frulloni L, Gabbrielli A, Pezzilli R, et al. Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig Liver Dis 2009; 41: 311-7. [Crossref]
18. Hirota M, Shimosegawa T, Masamune A, et al. The seventh nationwide epidemiological survey for chronic pancreatitis in Japan: clinical significance of smoking habit in Japanese patients. Pancreatology 2014; 14: 490-6. [Crossref]
19. Wang LW, Li ZS, Li SD, Jin ZD, Zou DW, Chen F. Prevalence and clinical features of chronic pancreatitis in China: a retrospective multicenter analysis over 10 years. Pancreas 2009; 38: 248-54. [Crossref]
20. Fernandez M, Arvanitakis M, Musala C, et al. The Belgian national registry on chronic pancreatitis: A prospective multi-centre study covering more than 800 patients in one year. Pancreatology 2017; 17: 572-9. [Crossref]
21. Balakrishnan V, Unnikrishnan AG, Thomas V, et al. Chronic pancreatitis. A prospective nationwide study of 1,086 subjects from India. JOP 2008; 9: 593-600.
22. Şişman G, Köroğlu E, Erzin Y, Hatemi İ, Tuncer M, Şentürk H. Demographic characteristics of chronic pancreatitis patients in the era of endosonography: Experience of a single tertiary referral center in Turkey. Turk J Gastroenterol 2016 May; 27: 284-9. [Crossref]
23. Ryu JK, Lee JK, Kim YT, et al. Clinical features of chronic pancreatitis in Korea: a multicenter nationwide study. Digestion 2005; 72: 207-11. [Crossref]
24. Yadav D, Whitcomb DC. The role of alcohol and smoking in pancreatitis. Nat Rev Gastroenterol Hepatol 2010; 7: pp. 131-45. [Crossref]
25. Lévy P, Mathurin P, Roqueplo A, Rueff B, Bernades P. A multidimensional case-control study of dietary, alcohol, and tobacco habits in alcoholic men with chronic pancreatitis. Pancreas 1995; 10: 231-8. [Crossref]
26. Wilson JS, Bernstein L, McDonald C, Tait A, McNeil D, Pirola RC. Diet and drinking habits in relation to the development of alcoholic pancreatitis. Gut 1985; 26: 882-7. [Crossref]
27. Samokhvalov AV, Rehm J, Roerecke. Alcohol Consumption as a Risk Factor for Acute and Chronic Pancreatitis: A Systematic Review and a Series of Meta-analyses. M EBioMedicine 2015; 2: 1996-2002. [Crossref]
28. Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009; 169: 1035-45. [Crossref]
29. Ietiansen L, Gronbaek M, Becker U, Tolstrup JS. Risk of pancreatitis according to alcohol drinking habits: a population-based cohort study. Am J Epidemiol 2008; 168: 932-7. [Crossref]
30. Lankisch MR, Imoto M, Layer P, DiMagno EP. The effect of small amounts of alcohol on the clinical course of chronic pancreatitis. Mayo Clin Proc 2001; 76: 242-51. [Crossref]
31. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144: 1252-61. [Crossref]
32. Machicado JD, Chari ST, Timmons L, Tang G, Yadav D. A population-based evaluation of the natural history of chronic pancreatitis. Pancreatology 2018; 18: 39-45. [Crossref]
33. Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno E. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107: 1481-7. [Crossref]
34. Ammann RW, Muellhaupt B, Meyenberger C, Heitz PU. Alcoholic nonprogressive chronic pancreatitis: prospective long-term study of a large cohort with alcoholic acute pancreatitis (1976-1992). Pancreas 1994; 9: 365-73. [Crossref]
35. Morton C, Klatsky AL, Udaltsova N. Smoking, coffee, and pancreatitis. Am J Gastroenterol 2004; 99: 731-8. [Crossref]
36. Tolstrup JS, Kristiansen L, Becker U, Gronbaek M. Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study. Arch Intern Med 2009; 169: 603-9. [Crossref]
37. Andriulli A, Botteri E, Almasio PL, et al. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas 2010; 39: 1205-10. [Crossref]
38. Pfützer RH, Barmada MM, Brunskill AP, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000; 119: 615-23. [Crossref]
39. Bishop MD, Freedman SD, Zielenski J, et al. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum Genet 2005; 118: 372-81. [Crossref]
40. Zhou J, Sahin-Tóth M. Chymotrypsin C mutations in chronic pancreatitis. J Gastroenterol Hepatol 2011; 26: 1238-124. [Crossref]
41. Cotton PB. Congenital anomaly of pancreas divisum can cause obstructive pain and pancreatitis. Gut 1980; 21: 105-14. [Crossref]
42. Bernard JP, Sahel J, Giovannini M, Sarles H. Pancreas divisum is probable cause of acute pancreatitis: a report of 137 cases. Pancreas 1990; 5: 248-54. [Crossref]
43. Rizzo RJ, Szucs RA, Turner MA. Congenital abnormalities of the pancreas and biliary tree in adults. Radiographics 1995; 15: 49-68. [Crossref]
44. Delhaye M, Engelholm L, Cremer M. Pancreas divisum: congenital anatomic variant or anomaly? Contribution of endoscopic retrograde dorsal pancreatography. Gastroenterology 1985; 89: 951-8. [Crossref]
45. Lehman GA, Sherman S. Pancreas divisum. Diagnosis, clinical significance, and management alternatives. Gastrointest Endosc Clin N Am 1995; 5: 145-70. [Crossref]
46. Nishino T, Toki F, Oyama H, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005; 30: 76-82.
47. Maruyama M, Arakura N, Ozaki Y, et al. Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients. Int J Rheumatol 2013; 5: 1-8. [Crossref]
48. Maire F, Le Baleur Y, Rebours V, et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol 2011; 106: 151-6. [Crossref]
49. Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682-707. [Crossref]
50. Whitcomb DC. Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist with topic reviews, updates, and use primers. Clin Transl Gastroenterol 2019; 10: e00027. [Crossref]
51. Schneider A, Löhr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol 2007; 42: 101-19. [Crossref]
52. Schneider A, Pfutzer RH. Treatment of alcoholic pancreatitis. Dig Dis Sci 2005; 23: 241-6. [Crossref]
53. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004; 2: 252-61. [Crossref]
54. Rustagi T, Njei B. Magnetic Resonance Cholangiopancreatography in the Diagnosis of Pancreas Divisum: A Systematic Review and Meta-analysis. Pancreas 2014; 43: 823-8. [Crossref]
55. Covantev S. Pancreas divisum: a reemerging risk factor for pancreatic diseases. Rom J Intern Med 2018; 56: 233-42. [Crossref]
56. Whitcomb DC. Genetic risk factors for pancreatic disorders. Gastroenterology 2013; 144: 1292-302. [Crossref]
57. Hegyi P, Wilschanski M, Muallem S, et al. CFTR: A new horizon in the pathomechanism and treatment of pancreatitis. Rev Phsiol Biochem Pharmacol 2016; 170: 37-66. [Crossref]
58. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14: 141-5. [Crossref]
59. Giefer MJ, Lowe ME, Werlin SL, et al. Early-Onset Acute Recurrent and Chronic Pancreatitis Is Associated with PRSS1 or CTRC Gene Mutations. J Pediatr 2017; 186: 95-100. [Crossref]
60. Hu C, Wen L, Deng L, et al. The Differential Role of Human Cationic Trypsinogen (PRSS1) p.R122H Mutation in Hereditary and Nonhereditary Chronic Pancreatitis: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2017; 2017: 9505460. [Crossref]
61. Di Leo M, Bianco M, Zuppardo RA, et al. Meta-analysis of the impact of SPINK1 p.N34S gene variation in Caucasic patients with chronic pancreatitis. An update. Dig Liver Dis 2017; 49: 847-53. [Crossref]
62. Oruç N, Osmanoğlu N, Aktan Ç, Berdeli A, Özütemiz AÖ. Common SPINK-1 genetic mutations do not predispose to Crohn’s Disease. Turk J Med Sci 2017; 47: 1300-1. [Crossref]
63. Gomez-Lira M, Bonamini D, Castellani C, et al. Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients. Eur J Hum Genet 2003; 11: 543-6. [Crossref]
64. Ooi CY, Dorfman R, Cipolli M, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology 2011; 140: 153-61. [Crossref]
65. Şişman G, Tuğcu M, Ayla K, Sebati Ö, Şentürk H. Mutation analysis of PRSS1, SPINK1 and CFTR gene in patients with alcoholic and idiopathic chronic pancreatitis: A single center study. Turk J Gastroenterol 2015; 26: 176-80. [Crossref]
66. Rosendahl J, Witt H, Szmola R, et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008; 40: 78-82. [Crossref]
67. Masson E, Chen JM, Scotet V, Le Marachal C, Farec C. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet 2008; 123: 83-91. [Crossref]
68. Muddana V, Lamb J, Greer JB, et al. Association between calcium sensing receptor gene polymorphisms and chronic pancreatitis in a US population: role of serine protease inhibitor Kazal 1type and alcohol. World J Gastroenterol 2008; 14: 4486-91. [Crossref]
69. Raeder H, Johansson S, Holm PI, et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 2006; 38: 54-62. [Crossref]
70. Witt H, Beer S, Rosendahl J, et al. Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet 2013; 45: 1216-20. [Crossref]
71. Zhong Y, Zou R, Cao J, Peng M. Glutathione S-transferase M1 and glutathione S-transferase T1 genotype in chronic pancreatitis: a meta-analysis. J Int Med Res 2015; 43: 9-16. [Crossref]
72. Zhong Y, Cao J, Zou R, Peng M. Genetic polymorphisms in alcohol dehydrogenase, aldehyde dehydrogenase and alcoholic chronic pancreatitis susceptibility: a meta-analysis. Gastroenterol Hepatol 2015; 38: 417-25. [Crossref]
73. Vatansever S, Tekin F, Salman E, Altintoprak E, Coskunol H, Akarca US. Genetic polymorphisms of ADH1B, ADH1C and ALDH2 in Turkish alcoholics: lack of association with alcoholism and alcoholic cirrhosis. Bosn J Basic Med Sci 2015; 15: 37-41. [Crossref]
74. Meng Q, Xin L, Liu W, et al. Diagnosis and Treatment of Autoimmune Pancreatitis in China: A Systematic Review. PLoS One 2015; 25: 10: e0130466. [Crossref]
75. Matsubayashi H, Kakushima N, Takizawa K, et al. Diagnosis of autoimmune pancreatitis. World J Gastroenterol 2014; 20: 16559-69. [Crossref]
76. Okazaki K, Uchida K, Oha M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000; 118: 573-81. [Crossref]
77. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40: 352-8. [Crossref]
78. Matsubayashi H, Yoneyama M, Nanri K, et al. Determination of steroid response by abdominal ultrasound in cases with autoimmune pancreatitis. Dig Liver Dis 2013; 45: 1034-40. [Crossref]
79. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58: 1504-7. [Crossref]
80. Rizk MK, Gerke H. Utility of endoscopic ultrasound in pancreatitis: a review. World J Gastroenterol 2007; 13: 6321-6. [Crossref]
81. Drewes AM, Bouwense SAW, Campbell CM, et al. Guidelines for the understanding and management of pain in chronic pancreatitis. Pancreatology 2017; 17: 720-31. [Crossref]
82. Bockman DE, Buchler M, Malfertheiner P, Beger HG. Analysis of nerves in chronic pancreatitis. Gastroenterology 1988; 94: 1459-69. [Crossref]
83. Ceyhan GO, Michalski CW, Demir IE, Müller MW, Friess H. Pancreatic pain. Best Pract Res Clin Gastroenterol 2008; 22: 31-44. [Crossref]
84. Karanjia ND, Reber HA. The cause and management of the pain of chronic pancreatitis. Gastroenterol Clin North Am 1990; 19: 895-904.
85. Ebbehoj N, Borly L, Madsen P, Svendsen LB. Pancreatic tissue pressure and pain in chronic pancreatitis. Pancreas 1986; 1: 556-8. [Crossref]
86. Dimcevski G, Sami SA, Funch-Jensen P, et al. Pain in chronic pancreatitis: the role of reorganization in the central nervous system. Gastroenterology 2007; 132: 1546-56. [Crossref]
87. Gubergrits N, Malecka-Panas E, Lehman GA, et al. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther 2011; 33: 1152-61. [Crossref]
88. Ammann RW, Muellhaupt B. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 1999; 116: 1132-40. [Crossref]
89. Mullady DK, Yadav D, Amann ST, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Gut 2011; 60: 77-84. [Crossref]
90. Anderson MA, Akshintala V, Albers KM, et al. Mechanism, assessment and management of pain in chronic pancreatitis: Recommendations of a multidisciplinary study group. Pancreatology 2016; 16: 83-94. [Crossref]
91. Bouwense SA, Buscher HC, van Goor H, Wilder-Smith OHG. S-ketamine modulates hyperalgesia in patients with chronic pancreatitis pain. Reg Anesth Pain Med 2011; 36: 303-7. [Crossref]
92. Madzak A, Olesen SS, Lykke Poulsen J, Mark EB, Drewes AM, Frokjaer JB. MRI assessed pancreatic morphology and exocrine function are associated with disease burden in chronic pancreatitis. Eur J Gastroenterol Hepatol 2017; 29: 1269-75. [Crossref]
93. Hao L, Liu Y, Wang T, et al. Extracorporeal shock wave lithotripsy is safe and effective for geriatric patients with chronic pancreatitis. J Gastroenterol Hepatol 2019; 34: 466-73.
94. Pezzilli R, Morselli-Labate AM, Frulloni L, et al. The quality of life in patients with chronic pancreatitis evaluated using the SF-12 questionnaire: a comparative study with the SF-36 questionnaire. Dig Liver Dis 2006; 38: 109-15. [Crossref]
95. Bloechle C, Izbicki JR, Knoefel WT, Kuechler T, Broelsch CE. Quality of life in chronic pancreatitis--results after duodenum-preserving resection of the head of the pancreas. Pancreas 1995; 11: 77-85. [Crossref]
96. Andersen PL, Madzak A, Olesen SS, Drewes AM, Frokjaer JB. Quantification of parenchymal calcifications in chronic pancreatitis: relation to atrophy, ductal changes, fibrosis and clinical parameters. Scand J Gastroenterol 2018; 53: 218-24. [Crossref]
97. Wassef W, Bova C, Barton B, Hartigan C. Pancreatitis Quality of Life Instrument: Development of a new instrument. SAGE Open Med 2014; 2: 2050312114520856. [Crossref]
98. Pongprasobchai S. Maldigestion from pancreatic exocrine insufficiency. J Gastroenterol Hepatol 2013; 28: 99-102. [Crossref]
99. Owens SR, Greenson JK. The pathology of malabsorption: current concepts. Histopathology 2007; 50: 64-82. [Crossref]
100. Shandro BM, Nagarajah R, Poullis A. Challenges in the management of pancreatic exocrine insufficiency. World J Gastrointest Pharmacol Ther 2018; 9: 39-46. [Crossref]
101. Forsmark CE. Diagnosis and Management of Exocrine Pancreatic Insufficiency. Curr Treat Options Gastroenterol 2018; 16: 306-15. [Crossref]
102. Durie P, Baillargeon JD, Bouchard S, Donnellan F, Zepeda-Gomez S, Teshima C. Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel. Curr Med Res Opin 2018; 34: 25-33. [Crossref]
103. Rothenbacher D, Löw M, Hardt PD, Klör HU, Ziegler H, Brenner H. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study. Scand J Gastroenterol 2005; 40: 697-704. [Crossref]
104. Othman MO, Harb D, Barkin JA. Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician. Int J Clin Pract 2018; 72: e13066. [Crossref]
105. Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev 2012; 28: 338-42. [Crossref]
106. Mohapatra S, Majumder S, Smyrk TC, et al. Diabetes Mellitus Is Associated with an Exocrine Pancreatopathy Conclusions From a Review of Literature. Pancreas 2016; 45: 1104-10. [Crossref]
107. Enrique Domínguez Muñoz J. Diagnosis of chronic pancreatitis: Functional testing. Best Pract Res Clin Gastroenterol 2010; 24: 233-41. [Crossref]
108. Löser C, Möllgaard A, Fölsch UR. Faecal elastase 1: a novel, highly sensitive and specific tubeless pancreatic function test. Gut 1996; 39: 580-6. [Crossref]
109. Domínguez-Muñoz JE, Hyeronimus C, Sauerbruch T, Malfertheiner P. Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol 1995; 90: 1834-7.
110. Stein J, Jung M, Sziegoleit A, Zeuzem S, Caspary F, Lembcke B. Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem 1996; 42: 222-6. [Crossref]
111. Lankisch PG, Schmidt I, König H, et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insuficiency. Gut 1998; 42: 551-4. [Crossref]
112. Lüth S, Teyssen S, Forssmann K, Kölbel C, Krummenauer F, Singer MV. Fecal Elastase-1 Determination: ‘Gold Standard’ of Indirect Pancreatic Function Tests? Scand J Gastroenterol 2001; 36: 1092-9. [Crossref]
113. Vanga RR, Tansel A, Sidiq S, El-Serag HB, Othman MO. Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2018; 16: 1220-8. [Crossref]
114. Ventrucci M, Cipolla A, Ubalducci, Roda A, Roda E. 13C-labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency. Gut 1998; 42: 81-7. [Crossref]
115. Domínguez-Muñoz JE, Iglesias-García J, Vilariño-Insua M, Iglesias-Rey M. 13C-mixedtriglyceridebreathtesttoassessoral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 484-8. [Crossref]
116. Domínguez-Muñoz JE, Nieto L, Vilariño M, Lourido MV, García JI. Development and Diagnostic Accuracy of a Breath Test for Pancreatic Exocrine Insufficiency in Chronic Pancreatitis. Pancreas 2016; 45: 241-7. [Crossref]
117. Gonzalez-Sanchez V, Amrani R, Gonzalez V, Trigo C, Pico A, de-Madaria E. Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: 13C-Mixed Triglyceride Breath Test versus Fecal Elastase. Pancreatology 2017; 17: 580-5. [Crossref]
118. Löser C, Brauer C, Aygen S, Hennemann O, Fölsch UR. Comparative Clinical Evaluation of the 13C-Mixed Triglyceride Breath Test as an Indirect Pancreatic Function Test. Scand J Gastroenterol 1998; 33: 327-34. [Crossref]
119. Manfredi R, Mucelli RP. Secretin-enhanced MR Imaging of the Pancreas. Radiology 2016; 279: 29-43. [Crossref]
120. Cappeliez O, Delhaye M, Devière J, et al. Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 2000; 215: 358-64. [Crossref]
121. Balci NC, Smith A, Momtahen AJ, et al. MRI and S-MRCP findings in patients with suspected chronic pancreatitis: correlation with endoscopic pancreatic function testing (ePFT). J Magn Reson Imaging 2010; 31: 601-6. [Crossref]
122. Hansen TM, Nilsson M, Gram M, Frøkjær JB. Morphological and functional evaluation of chronic pancreatitis with magnetic resonance imaging. World J Gastroenterol 2013; 19: 7241-6. [Crossref]
123. Bian Y, Wang L, Chen C, et al. Quantification of pancreatic exocrine function of chronic pancreatitis with secretin-enhanced MRCP. World J Gastroenterol 2013; 19: 7177-82 . [Crossref]
124. Introduction: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41(Suppl 1): 1-2. [Crossref]
125. Hardt PD, Brendel MD, Kloer HU, Bretzel RG. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care 2008; 31 Suppl 2: 165-9. [Crossref]
126. Vujasinovic M, Tepes B, Makuc J, et al. Pancreatic exocrine insufficiency, diabetes mellitus and serum nutritional markers after acute pancreatitis. World J Gastroenterol 2014; 20: 18432-8. [Crossref]
127. Dominguez-Munoz JE, Lucendo A, Carballo LF, Iglesias-Garcia J, Tenias JM. A. Spanish multicenter study to estimate the prevalence and incidence of chronic pancreatitis and its complications. Rev Esp Enferm Dig 2014; 106: 239-45.
128. Woodmansey C, McGovern AP, McCullough KA, et al. Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study. Diabetes Care 2017; 40: 1486-93. [Crossref]
129. Wang W, Guo Y, Liao Z, et al. Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis. Pancreas 2011; 40: 206-12. [Crossref]
130. Rickels MR, Bellin M, Toledo FG, et al. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. Pancreatology 2013; 13: 336-42. [Crossref]
131. Seymour NE, Volpert AR, Lee EL, Andersen DK, Hernandez C. Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide. Am J Surg 1995; 169: 105-9. [Crossref]
132. Nathan JD, Zdankiewicz PD, Wang J, et al. Impaired hepatocyte glucose transport protein (GLUT2) internalization in chronic pancreatitis. Pancreas 2001; 22: 172-8. [Crossref]
133. Kiechl S, Wittmann J, Giaccari A, et al. Blockade of receptor activator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med 2013; 19: 358-63. [Crossref]
134. Zhou X, You S. Rosiglitazone inhibits hepatic insulin resistance induced by chronic pancreatitis and IKK-beta/NF-kappaB expression in liver. Pancreas 2014; 43: 1291-8. [Crossref]
135. Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology 2011; 11: 279-94. [Crossref]
136. Couet C, Genton P, Pointel JP, et al. The prevalence of retinopathy is similar in diabetes mellitus secondary to chronic pancreatitis with or without pancreatectomy and in idiopathic diabetes mellitus. Diabetes Care 1985; 8: 323-8. [Crossref]
137. Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol 2013; 19: 7258-66. [Crossref]
138. Nair RJ, Lawler L, Miller MR. Chronic pancreatitis. Am Fam Physician 2007; 76: 1679-88.
139. Muniraj T, Aslanian HR, Farrell J, Jamidar PA. Chronic pancreati-tis, a comprehensive review and update. Part II: Diagnosis, complica-tions, and management. Dis Mon 2015; 61: 5-37.
140. Oh HC, Kwon CI, El Hajj II, et al. Low Serum Pancreatic Amylase and Lipase Values Are Simple and T-USGeful Predictors to Diagnose Chronic Pancreatitis. Gut Liver 2017; 11: 878-83. [Crossref]
141. Gullo L, Costa PL, Fontana G, LaboÁ G. Investigation of exocrine pancreatic function by continuoT-USG infT-USGion of caerulein and secretin in normal subjects and in chronic pancreatitis. Diges-tion 1976; 14: 97-107. [Crossref]
142. Niederau C, Grendell JH. Diagnosis of chronic pancreatitis. Gas-troenterology 1985; 88: 1973-95. [Crossref]
143. Glasbrenner B, Schön A, Klatt S, Beckh K, Adler G. Clinical eval-uation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis. Eur J Gastroenterol Hepatol 1996; 8: 1117-20.[Crossref]
144.Issa Y, Kempeneers MA, van Santvoort HC, Bollen TL, Bipat S, Boermeester MA. Diagnostic performance of imaging modalities in chronic pancreatitis: a systematic review and meta-analysis. Eur Radiol 2017; 27: 3820-44. [Crossref]
145.Pungpapong S, Wallace MB, Woodward TA, Noh KW, Raimon-do M. Accuracy of endoscopic ultrasonography and magnetic reso-nance cholangiopancreatography for the diagnosis of chronic pan-creatitis: a prospective comparison study. J Clin Gastroenterol 2007; 41: 88-93. [Crossref]
146.Buscail L, Escourrou J, Moreau J, et al. Endoscopic ultrasonog-raphy in chronic pancreatitis: a comparative prospective study with conventional ultrasonography, computed tomography, and ERKP. Pancreas 1995; 10: 251-7. [Crossref]
147.Dawwas MF, Taha H, Leeds JS, Nayar MK, Oppong KW. Diag-nostic accuracy of quantitative EUS elastography for discriminating malignant from benign solid pancreatic masses: a prospective, sin-glecenter study. Gastrointest Endosc 2012; 76: 953-61.
148.Dominguez-Muñoz JE, Iglesias-Garcia J, Castiñeira Alvariño M, Luaces Regueira M, Lariño-Noia J. EUS elastography to predict pan-creatic exocrine insufficiency in patients with chronic pancreatitis. Gastrointest Endosc 2015; 81: 136-42. [Crossref]
149.Yashima Y, Sasahira N, Isayama H, et al. Acoustic radiation force impulse elastography for noninvasive assessment of chronic pancreatitis. J Gastroenterol 2012; 47: 427-32. [Crossref]
150.Vijungco JD, Prinz RA. Management of biliary and duodenal complications of chronic pancreatitis. World J Surg 2003; 27: 1258-70. [Crossref]
151.Jha AK, Goenka MK, Goenka U. Chronic pancreatitis in EasternIndia: Experience from a tertiary care center. Indian J Gastroenterol2017; 36: 131-6. [Crossref]
152. Saluja SS, Kalayarasan R, Mishra PK, Srivastava S, Chandrasekar S, Godhi S. Chronic pancreatitis with benign biliary obstruction:management issues. World J Surg 2014; 38: 2455-9. [Crossref]
153.Hao L, Wang LS, Liu Y, et al. The different course of alcoholicand idiopathic chronic pancreatitis: A long-term study of 2,037 patients. PLoS One 2018; 13: e0198365. [Crossref]
154. Littenberg G, Afroudakis A, Kaplowitz N. Common bile duct stenosis from chronic pancreatitis: a clinical and pathologic spectrum.Medicine (Baltimore) 1979; 58: 385-412. [Crossref]
155. Rigauts H, Marchal G, Van Steenbergen W, Ponette E. Comparison of ultrasound and E.R.C.P. in the detection of the cause of obstructive biliary disease. Rofo 1992; 156: 252-7. [Crossref]
156. Materne R, Van Beers BE, Gigot JF, et al. Extrahepatic biliary obstruction: magnetic resonance imaging compared with endoscopicultrasonography. Endoscopy 2000; 32: 3. [Crossref]
157. Saifuku Y, Yamagata M, Koike T, et al. Endoscopic ultrasonography can diagnose distal biliary strictures without a mass on computed tomography. World J Gastroenterol 2010; 16: 237-44. [Crossref]
158. Huizinga WK, Baker LW. Surgical intervention for regional complications of chronic pancreatitis. Int Surg 1993; 78: 315-9.
159.Aranha GV, Prinz RA, Greenlee HB, Freeark RJ. Gastric outletand duodenal obstruction from inflammatory pancreatic disease.Arch Surg 1984; 119: 833-5. [Crossref]
160.Bradley EL, 3rd, Clements JL, Jr. Idiopathic duodenal obstruction: an unappreciated complication of pancreatitis. Ann Surg 1981; 193: 638-48. [Crossref]
161. Kozarek RA, Sanowski RA. Duodenal and common bile duct obstruction in pancreatitis simulating carcinoma. J Clin Gastroenterol1981; 3: 53-9. [Crossref]
162.Archer S, Levitt S, Drury P. Duodenal necrosis and intramuralhaematoma complicating acute pancreatitis. Aust N Z J Surg 1991;61: 542-4. [Crossref]
163.Rheingold OJ, Walker JA, Barkin JS. Gastric outlet obstructiondue to a pancreatic pseudocyst: report of two cases. Am J Gastroenterol 1978; 69: 92-6.
164. Brust R, Chen KC. Acute hemorrhagic pancreatitis complicated by duodenal obstruction. Report of a case. Am J Roentgenol Radium Ther Nucl Med 1962; 87: 732-5.
165.Xu W, Qi X, Chen J, Su C, Guo X. Prevalence of Splanchnic VeinThrombosis in Pancreatitis: A Systematic Review and Meta-Analysis of Observational Studies. Gastroenterol Res Pract 2015; 2015:245460. [Crossref]
166.Wang L, Liu GJ, Chen YX, Dong HP, Zhang YQ, Wang LX. Combined use of D-dimer and P-selectin for the diagnosis of splenic orportal vein thrombosis following splenectomy. Thromb Res 2010;125: e206-9. [Crossref]
167.Jiang W, Zhou J, Ke L, et al. Splanchnic vein thrombosis in necrotizing acute pancreatitis: Detection by computed tomographicvenography. World J Gastroenterol 2014; 20: 16698-701. [Crossref]
168. Cakmak O, Elmas N, Tamsel S, et al. Role of contrast-enhanced 3D magnetic resonance portography in evaluating portal venoussystem compared with color Doppler ultrasonography. Abdom Imaging 2008; 33: 65-71. [Crossref]
169.Chiang KC, Chen TH, Hsu JT. Management of chronic pancreatitis complicated with a bleeding pseudoaneurysm. World J Gastroenterol 2014; 20: 16132-7. [Crossref]
170.Hsu JT, Yeh CN, Hung CF, et al. Management and outcome ofbleeding pseudoaneurysm associated with chronic pancreatitis.BMC Gastroenterol 2006; 6: 3-8. [Crossref]
171. Vander Mijnsbrugge W, Laleman W, Van Steenbergen W, Heye S, Verslype C, Maleux G. Long-term clinical and radiological outcomeof endovascular embolization of pancreatitis-related pseudoaneurysms. Acta Radiol 2017; 58: 316-22. [Crossref]
172. Zhou LY, Xie XY, Chen D, Lü MD. Contrast-enhanced ultrasound in detection and follow-up of pancreaticoduodenal artery pseudoaneurysm: a case report. Chin Med J (Engl) 2011; 124: 2792-4.
173. Yamanaka Y, Ishida H, Naganuma H, et al. Superb microvascular imaging (SMI) findings of splenic artery pseudoaneurysm: a report of two cases. J Med Ultrason (2001) 2018; 45: 515-23. [Crossref]
174.Dörffel T, Wruck T, Rückert RI, Romaniuk P, Dörffel Q, WermkeW.Vascular complications in acute pancreatitis assessed by colorduplex ultrasonography. Pancreas 2000; 21: 126-33. [Crossref]
175.Gunjan D, Gamanagatti S, Garg P. Endoscopic ultrasonography-guided obliteration of a left inferior phrenic artery pseudoaneurysm in a patient with alcoholic chronic pancreatitis. Endoscopy2018; 50: 449-50. [Crossref]
176. Rai P, Bhera B, Sharma M. First report of successful treatment of splenic artery pseudoaneurysm with endoscopic ultrasound-guided coil and glue. Endoscopy 2017; 49: E179-80. [Crossref]
177. Fukatsu K, Ueda K, Maeda H, et al. A case of chronic pancreatitis in which endoscopic ultrasonography was effective in the diagnosis of a pseudoaneurysm. World J Gastrointest Endosc 2012; 4: 335-8. [Crossref]
178. Bergert H, Hinterseher I, Kersting S, Leonhardt J, Bloomenthal A, Saeger HD. Management and outcome of hemorrhage due to arterial pseudoaneurysms in pancreatitis. Surgery 2005; 137: 323-8. [Crossref]
179. Gabrielli D, Taglialatela F, Mantini C, Giammarino A, Modestino F, Cotroneo AR. Endovascular Treatment of Visceral Artery Pseudoaneurysms in Patients with Chronic Pancreatitis: Our Single-Center Experience. Ann Vasc Surg 2017; 45: 112-6. [Crossref]
180. Gullo L, Barbara L, Labo G. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology 1988 ;95: 1063-8. [Crossref]
181. Maisonneuve P, Lowenfels AB, Mullhaupt B, et al. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut 2005; 54: 510-4. [Crossref]
182. Bourliere M, Barthet M, Berthezene P, Durbec JP, Sarles H. Is tobacco a risk factor for chronic pancreatitis and alcoholic cirrhosis? Gut 1991; 32: 1392-5. [Crossref]
183. Talamini G, Bassi C, Falconi M, et al. Smoking cessation at the clinical onset of chronic pancreatitis and risk of pancreatic calcifications. Pancreas 2007; 35: 320-6. [Crossref]
184. Han S, Kheder J, Bocelli L, et al. Smoking Cessation in a Chronic Pancreatitis Population. Pancreas 2016; 45: 1303-8. [Crossref]
185. Lindkvist B, Dominguez-Munoz JE, Luaces-Regueira M, et al. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreatology 2012; 12: 305-10. https://doi.org/10.1016/j.pan.2012.04.006 [Crossref]
186. Sikkens EC, Cahen DL, Koch AD, et al. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology 2013; 13: 238-42. [Crossref]
187. Duggan SN, Smyth ND, O’Sullivan M, Feehan S, Ridgway PF, Conlon KC. The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis. Nutr Clin Pract 2014; 29: 348-54. [Crossref]
188. Marotta F, Labadarios D, Frazer L, Girdwood A, Marks IN. Fat-soluble vitamin concentration in chronic alcohol-induced pancreatitis. Relationship with steatorrhea. Dig Dis Sci 1994; 39: 993-8. [Crossref]
189. Meier R, Ockenga J, Pertkiewicz M, et al. ESPEN Guidelines on Enteral Nutrition: Pancreas. Clin Nutr 2006; 25: 275-84. [Crossref]
190. Haas S, Krins S, Knauerhase A, Löhr M. Altered bone metabolism and bone density in patients with chronic pancreatitis and pancreatic exocrine insufficiency. JOP 2015; 16: 58-62.
191. Min M, Patel B, Han S, et al. Exocrine Pancreatic Insufficiency and Malnutrition in Chronic Pancreatitis: Identification, Treatment, and Consequences. Pancreas 2018; 47: 1015-8. [Crossref]
192. Hoogenboom SA, Lekkerkerker SJ, Fockens P, Boermeester MA, van Hooft JE. Systematic review and meta-analysis on the prevalence of vitamin D deficiency in patients with chronic pancreatitis. Pancreatology 2016; 16: 800-6. [Crossref]
193. Duggan SN, Smyth ND, Murphy A, et al. High prevalence of osteoporosis in patients with chronic pancreatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2014; 12: 219-28. [Crossref]
194. Regunath H, Shivakumar BM, Kurien A, Satyamoorthy K, Pai CG. Anthropometric measurements of nutritional status in chronic pancreatitis in India: comparison of tropical and alcoholic pancreatitis. Indian J Gastroenterol 2011; 30: 78-83. [Crossref]
195. Olesen SS, Frandsen LK, Poulsen JL, Vestergaard P, Rasmussen HH, Drewes AM. The prevalence of underweight is increased in chronic pancreatitis outpatients and associates with reduced life quality. Nutrition 2017; 43-44: 1-7. [Crossref]
196. Hintaran AD, Chenault MN, Verhaegh BPM, Reijven PLM, Masclee AAM, Keulemans YCA. Improving nutritional status assessment in patients with chronic pancreatitis. Pancreatology 2018; 18: 785-91. [Crossref]
197. Gianotti L, Meier R, Lobo DN, et al. ESPEN Guidelines on Parenteral Nutrition: pancreas. Clin Nutr 2009; 28: 428-35. [Crossref]
198. Mirtallo JM, Forbes A, McClave SA, et al. International consensus guidelines for nutrition therapy in pancreatitis. JPEN 2012; 36: 284-91. [Crossref]
199. Giger U, Stanga Z, DeLegge MH. Management of chronic pancreatitis. Nutr Clin Pract 2004; 19: 37-49. [Crossref]
200. Duggan S, O’Sullivan M, Feehan S, Ridgway P, Conlon K. Nutrition treatment of deficiency and malnutrition in chronic pancreatitis: a review. Nutr Clin Pract 2010; 25: 362-70. [Crossref]
201. Singh S, Midha S, Singh N, Joshi YK, Garg PK. Dietary counseling versus dietary supplements for malnutrition in chronic pancreatitis: a randomized controlled trial. Clin Gastroenterol Hepatol 2008; 6: 353-9. [Crossref]
202. Forsmark CE. Management of Chronic Pancreatitis. Gastroenterology 2013; 144: 1282-91. [Crossref]
203. Chauhan S, Forsmark CE. Pain management in chronic pancreatitis: A treatment algorithm. Best Prac Research Clin Gastroenterol 2010; 24: 323-35. [Crossref] 204. Vargas-Schaffer G. Is the WHO nalgesic ladder still valid? Can Fam Physician 2010; 56: 514-7.
205. Wilder-Smith CH, Hill L, Osler W, O’ Keefe S. Effect of Tramadol and Morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis. Dig Dis Sci 1999; 44: 1107-16. [Crossref]
206. Niemann T, Madsen LG, Larsen S, Thorsgaard N. Opioid treatment of painful chronic pancreatitis. Int J Pancreatol 2000; 27: 235-40. [Crossref]
207. Olesen SS, Bouwense SA, Wilder-Smith OH, van Goor H, Drewes AM. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized controlled trial. Gastroenterology 2011; 141: 536-43. [Crossref]
208. Cartmell MT, O’Reilly DA, Porter C, Kingsnorth AN. A double-blind placebo-controlled trial of leukotriene receptor antagonist in chronic pancreatitis in humans. J Hepatobiliary Pancreat Surg 2004; 11: 255-9. [Crossref]
209. De Vries M, van Rijckevorsel DCM, Vissers KCP, Wilder-Smith OHG, van Goor H. Tetrahydrocannabiol does not reduce pain in patients with chronic abdominal pain in a Phase-2 placebo-controlled study. Clin Gastroenterol Hepatol 2017; 15: 1079-86. [Crossref]
210. Malfertheiner P, Mayer D, Büchler M, Dominguez-Munoz JE, Schiefer B, Ditschuneit H. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 1995; 36: 450-4. [Crossref]
211. Yaghoobi M, McNabb-Baltar J, Bijarchi R, Cotton PB. Pancreatic enzyme supplements are not effective relieving abdominal pain in patients with chronic pancreatitis: meta-analysis and systematic review of randomized controlled trials. Can J Gastroenterol Hepatol 2016; 2016: 8541839. [Crossref]
212. Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 1983; 28: 97-102. [Crossref]
213. Rustagi T, Njei B. Antioxidant therapy for pain reduction in patients with chronic pancreatitis: a systematic review and meta-analysis. Pancreas 2015; 44: 812-8. [Crossref]
214. Zhou D, Wang W, Cheng X, Wei J, Zheng S. Antioxidant therapy for patients with chronic pancreatitis: A systematic review and meta-analysis. Clin Nutr 2015; 34: 627-34. [Crossref]
215. Ahmed Ali U, Jens S, Busch OR, et al. Antioxidants for pain in chronic pancreatitis. Cochrane Database Syst Rev 2014; 21: CD008945. [Crossref]
216. Cai GH, Huang J, Zhao Y, et al. Antioxidant therapy for pain relief in patients with chronic pancreatitis: systematic review and meta-analysis. Pain Physician 2013; 16: 521-32.
217. Talukdar R, Murthy HV, Reddy DN. Role of methionine containing antioxidant combination in the management of pain in chronic pancreatitis: a systematic review and meta-analysis. Pancreatology 2015; 15: 136-44. [Crossref]
218. Jiang L, Ning D, Cheng Q, Chen XP. Endoscopic versus surgical drainage treatment of calcific chronic pancreatitis. Int J Surg 2018; 54: 242-7. [Crossref]
219. Costamagna G, Gabbrielli A, Mutignani M, Pandolfi M, Boscaini M, Crucitti F. Extracorporeal shock wave lithotripsy of pancreatic stones in chronic pancreatitis: immediate and medium-term results. Gastrointest Endosc 1997; 46: 231-6. [Crossref]
220. Farnbacher MJ, Schoen C, Rabenstein T, Benninger J, Hahn EG, Schneider HT. Pancreatic duct stones in chronic pancreatitis: criteria for treatment intensity and success. Gastrointest Endosc 2002; 56: 501-6. [Crossref]
221. Delhaye M, Vandermeeren A, Baize M, Cremer M. Extracorporeal shock-wave lithotripsy of pancreatic calculi. Gastroenterology 1992; 102: 610-20. [Crossref]
222. Dumonceau JM, Delhaye M, Tringali A, et al. Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2012; 44: 784-800. [Crossref]
223. Thomas M, Howell DA, Carr-Locke D, et al. Mechanical lithotripsy of pancreatic and biliary stones: complications and available treatment options collected from expert centers. Am J Gastroenterol 2007; 102: 1896-902. [Crossref]
224. Sherman S, Lehman GA, Hawes RH, et al. Pancreatic ductal stones: frequency of successful endoscopic removal and improvement in symptoms. Gastrointest Endosc 1991; 37: 511-7. [Crossref]
225. Nguyen-Tang T, Dumonceau JM. Endoscopic treatment in chronic pancreatitis, timing, duration and type of intervention. Best Pract Res Clin Gastroenterol 2010; 24: 281-98. [Crossref]
226. Moole H, Jaeger A, Bechtold ML, Forcione D, Taneja D, Puli SR. Success of Extracorporeal Shock Wave Lithotripsy in Chronic Calcific Pancreatitis Management: A Meta-Analysis and Systematic Review. Pancreas 2016; 45: 651-8. [Crossref]
227. Sauerbruch T, Holl J, Sackmann M, Paumgartner G. Extracorporeal lithotripsy of pancreatic stones in patients with chronic pancreatitis and pain: a prospective follow up study. Gut 1992; 33: 969-72. [Crossref]
228. Scheineder HT, May A, Benninger J, et al. Piezoelectric shock wave lithotripsy of pancreatic duct stones. Am J Gastroenterol 1994; 89: 2042-8.
229. van der Hul R, Plaisier P, Jeekel J, Terpstra O, den Toom R, Bruining H. Extracorporeal shock-wave lithotripsy of pancreatic duct stones: immediate and long-term results. Endoscopy 1994; 26: 573-8. [Crossref]
230. Dumonceau JM, Deviere J, LeMoine O, et al. Endoscopic pancreatic drainage in chronic pancreatitis associated with ductal stones: long-term results. Gastrointest Endosc 1996; 43: 547-55. [Crossref]
231. Johanns W, Jakobeit C, Greiner L, Janssen J. Ultrasound-guided extracorporeal shock wave lithotripsy of pancreatic ductal stones: Six years’ experience. Can J Gastroenterol 1996; 10: 471-5. [Crossref]
232. Adamek HE, Jakobs R, Buttmann A, Adamek MU, Schneider AR, Riemann JF. Long term follow up of patients with chronic pancreatitis and pancreatic stones treated with extracorporeal shockwave lithotripsy. Gut 1999; 45: 402-5. [Crossref]
233. Brand B, Kahl M, Sidhu S, et al. Prospective evaluation of morphology, function, and quality of life after extracorporeal shockwave lithotripsy and endoscopic treatment of chronic calcific pancreatitis. Am J Gastroenterol 2000; 95: 3428-38. [Crossref]
234. Kozarek RA, BrandaburJ J, Ball TJ, et al. Clinical outcomes in patients who undergo extracorporeal shockwave lithotripsy for chronic calcific pancreatitis. Gastrointest Endosc 2002; 56: 496-500. [Crossref]
235. Karasawa Y, Kawa S, Aoki Y, et al. Extracorporeal shock wave lithotripsy of pancreatic duct stones and patient factors related to stone disintegration. J Gastroenterol 2002; 37: 369-75. [Crossref]
236. Delhaye M, Arvanitakis M, Verset G, Cremer M, Deviere J. Long-term clinical outcome after endoscopic pancreatic ductal drainage for patients with painful chronic pancreatitis. Clin Gastroenterol Hepatol 2004; 2: 1096-106. [Crossref]
237. Tadenuma H, Ishihara T, Yamaguchi T, et al. Long-term results of extracorporeal shockwave lithotripsy and endoscopic therapy for pancreatic stones. Clin Gastroenterol Hepatol 2005; 3: 1128-35. [Crossref]
238. Dumonceau J-M, Costamagna G, Tringali A, et al. Treatment for painful calcified chronic pancreatitis: extracorporeal shock wave lithotripsy versus endoscopic treatment: a randomised controlled trial. Gut 2007; 56: 545-52. [Crossref]
239. Tandan M, Reddy DN, Santosh D, et al. Extracorporeal shock wave lithotripsy and endotherapy for pancreatic calculi- a large single center experience. Indian J Gastroenterol 2010; 29: 143-8. [Crossref]
240. Lawrence C, Siddiqi MF, Hamilton JN, et al. Chronic calcific pancreatitis: combination ERCP and extracorporeal shock wave lithotripsy for pancreatic duct stones. South Med J 2010; 103: 505-8. [Crossref]
241. Milovic V, Wehrmann T, Dietrich CF, Bailey AA, Caspary WF, Braden B. Extracorporeal shock wave lithotripsy with a transportable mini-lithotripter and subsequent endoscopic treatment improves clinical outcome in obstructive calcific chronic pancreatitis. Gastrointest Endosc 2011; 74: 1294-9. [Crossref]
242. Cahen DL, Gouma DJ, Laramée P, et al. Long-term outcomes of endoscopic vs surgical drainage of the pancreatic duct in patients with chronic pancreatitis. Gastroenterology 2011; 141: 1690-5. [Crossref]
243. Seven G, Schreiner MA, Ross AS, et al. Long-term outcomes associated with pancreatic extracorporeal shock wave lithotripsy for chronic calcific pancreatitis. Gastrointest Endosc 2012; 75: 997-1004. [Crossref]
244. Tandan M, Reddy DN, Talukdar R, et al. Long-term clinical outcomes of extracorporeal shockwave lithotripsy in painful chronic calcific pancreatitis. Gastrointest Endosc 2013; 78: 726-33. [Crossref]
245. Suzuki Y, Sugiyama M, Inui K, et al. Management for pancreatolithiasis: a Japanese multicenter study. Pancreas 2013; 42: 584-8. [Crossref]
246. Ohyama H, Mikata R, Ishihara T, et al. Efficacy of stone density on noncontrast computed tomography in predicting the outcome of extracorporeal shock wave lithotripsy for patients with pancreatic stones. Pancreas 2015; 44: 422-8. [Crossref]
247. Hu LH, Ye B, Yang YG, et al. Extracorporeal shock wave lithotripsy for Chinese patients with pancreatic stones: A prospective study of 214 cases. Pancreas 2016; 45: 298-305. [Crossref]
248. Li BR, Liao Z, Du TT, et al. Extracorporeal shockwave lithotripsy is a safe and effective treatment of pancreatic Stones coexiting with pancreatic pseudocysts. Gastrointest Endosc 2015; 1-10.
249. Korpela T, Udd M, Tenca A, et al. Long-term results of combined ESWL and ERCP treatment of chronic calcific pancreatitis. Scand J Gastroenterol 2016; 51: 866-71. [Crossref]
250. Vaysse T, Boytchev I, Antoni G, et al. Efficacy and safety of extracorporeal shock wave lithotripsy for chronic pancreatitis. Scand J Gastroenterol 2016; 51: 1380-5. [Crossref]
251. Lapp RT, Wolf JS Jr, Faerber GJ, et al. Duct diameter and size of stones predict successful extracorporeal shock wave lithotripsy and endoscopic clearance in patients with chronic pancreatitis and pancreaticolithiasis. Pancreas 2016; 45: 1208-11. [Crossref]
252. Haraldsson S, Roug S, Nøjgaard C, et al. Extracorporeal shock wave lithotripsy for pancreatic duct stones: an observational study. Scand J Gastroenterol 2018: 1-5. 253. Wang D, Ji JT, Xin L, et al. Extracorporeal shock wave lithotripsy for chronic pancreatitis patients with stones after pancreatic surgery. Pancreas 2018; 47: 609-16. [Crossref]
254. Choi EK, McHenry L, Watkins JL, et al. Use of intravenous secretin during extracorporeal shock wave lithotripsy to facilitate endoscopic clearance of pancreatic duct stones. Pancreatology 2012; 12: 272-5. [Crossref]
255. Ohara H, Hoshino M, Hayakawa T, et al. Single application extracorporeal shock wave lithotripsy is the first choice for patients with pancreatic duct stones. Am J Gastroenterol 1996; 91: 1388-94.
256. Inui K, Tazuma S, Yamaguchi T, et al. Treatment of pancreatic stones with extracorporeal shock wave lithotripsy: results of a multicenter survey. Pancreas 2005; 30: 26-30.
257. Talukdar R, Reddy DN. Pancreatic endotherapy for chronic pancreatitis. Gastrointest Endoscopy Clin N Am 2015; 25: 765-77. [Crossref]
258. Hirai T, Goto H, Hirooka Y, et al. Pilot study of pancreatoscopic lithotripsy using a 5-fr instrument: selected patients may benefit. Endoscopy 2004; 36: 212-6. [Crossref]
259. Howell DA, Dy RM, Hanson BL, Nezhad SF, Broaddus SB. Endoscopic treatment of pancreatic duct stones using a 10F pancreatoscope and electrohydraulic lithotripsy. Gastrointest Endosc 1999; 50: 829-33. [Crossref]
260. Fishman DS, Tarnasky PR, Patel SN, Raijman I. Management of pancreaticobiliary disease using a new intra-ductal endoscope: the Texas experience. World J Gastroenterol 2009; 15: 1353-8. [Crossref]
261. Maydeo A, Kwek BE, Bhandari S, Bapat M, Dhir V. Single-operator cholangioscopy-guided laser lithotripsy in patients with difficult biliary and pancreatic ductal stones (with videos). Gastrointest Endosc 2011; 74: 1308-14. [Crossref]
262. Alatawi A, Leblanc S, Vienne A, et al. Pancreatoscopy-guided intracorporeal laser lithotripsy for difficult pancreatic duct stones: a case series with prospective follow-up (with video). Gastrointest Endosc 2013; 78: 179-83. [Crossref]
263. Attwell AR, Brauer BC, Chen YK, Yen RD, Fukami N, Shah RJ. Endoscopic retrograde cholangiopancreatography with per oral pancreatoscopy for calcific chronic pancreatitis using endoscope and catheter-based pancreatoscopes: a 10-year single-center experience. Pancreas 2014; 43: 268-74. [Crossref]
264. Attwell AR, Patel S, Kahaleh M, Raijman IL, Yen R, Shah RJ. ERCP with per-oral pancreatoscopy-guided laser lithotripsy for calcific chronic pancreatitis: a multicenter U.S. experience. Gastrointest Endosc 2015; 82: 311-8. [Crossref]
265. Kurihara T, Yasuda I, Isayama H, et al. Diagnostic and therapeutic single-operator cholangiopancreatoscopy in biliopancreatic diseases: Prospective multicenter study in Japan. World J Gastroenterol 2016; 22: 1891-901. [Crossref]
266. Bekkali NL, Murray S, Johnson GJ, et al. Pancreatoscopy-directed electrohydraulic lithotripsy for pancreatic ductal stones in painful chronic pancreatitis using SpyGlass. Pancreas 2017; 46: 528-30. [Crossref]
267. Gutierrez OIB, Rajman I, Shah RJ, et al. International multicenter study on digital single operator pancreatoscopy for the management of pancreatic stones. Gastrointest Endosc 2018; 87: AB68.
268. Ogura T, Okuda A, Imanishi M, et al. Electrohydraulic lithotripsy for pancreatic duct stones under digital single-operator pancreatoscopy (with Video). Dig Dis Sci 2018 Nov 19. [Crossref]
269. Rosch T, Daniel S, Scholz M, et al. Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up. Endoscopy 2002; 34: 765-71. [Crossref]
270. Delhaye M, Matos C, Devière J. Endoscopic management of chronic pancreatitis. Gastrointest Endosc Clin N Am 2003; 13: 717-42. [Crossref]
271. Kim MH, Myung SJ, Kim YS, et al. Routine biliary sphincterotomy may not be indispensable for endoscopic pancreatic sphincterotomy. Endoscopy 1998; 30: 697-701. [Crossref]
272. Sauer BG, Gurka MJ, Ellen K, Shami VM, Kahalen M. Effect of pancreatic duct stent diameter on hospitalization in chronic pancreatitis: does size matter? Pancreas 2009; 38: 728-31. [Crossref]
273. Grimm H, Meyer WH, Nam WC, Soehendra N. New modalities for treating chronic pancreatitis. Endoscopy 1989; 21: 70-4. [Crossref]
274. Cremer M, Devière J, Delhaye M, Baize M, Vandermeeren A. Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy-six patients. Endoscopy 1991; 23: 171-6. [Crossref]
275. Ponchon T, Bory RM, Hedelius F, et al. Endoscopic stenting for pain relief in chronic pancreatitis: results of a standardized protocol. Gastrointest Endosc 1995;42: 452-6. [Crossref]
276. Smits ME, Badiga SM, Rauws EA, Tytgat GN, Huibregtse K. Long-term results of pancreatic stents in chronic pancreatitis. Gastrointest Endosc 1995; 42: 461-7. [Crossref]
277. Binmoeller KF, Jue P, Seifert H, Nam WC, Izbicki J, Soehendra N. Endoscopic pancreatic stent drainage in chronic pancreatitis and a dominant stricture: long-term results. Endoscopy 1995; 27: 638-44. [Crossref]
278. Laugier R, Renou C. Endoscopic ductal drainage may avoid resective surgery in painful chronic pancreatitis without large ductal dilatation. Int J Pancreatol 1998; 23: 145-52. [Crossref]
279. Morgan DE, Smith JK, Hawkins K, Wilcox CM. Endoscopic stent therapy in advanced chronic pancreatitis: relationships between ductal changes, clinical response, and stent patency. Am J Gastroenterol 2003; 98: 821-6. [Crossref]
280. Díte P, Ruzicka M, Zboril V, Novotný I. A prospective, randomized trial comparingendoscopic and surgical therapy for chronic pancreatitis. Endoscopy 2003; 35: 553-8. [Crossref]
281. Holm M, Matzen P. Stenting and extracorporeal shock wave lithotripsy in chronic pancreatitis. Scand J Gastroenterol 2003; 38: 328-31. [Crossref]
282. Vitale GC, Cothron K, Vitale EA, et al. Role of pancreatic duct stenting in the treatment of chronic pancreatitis. Surg Endosc 2004; 18: 1431-4. [Crossref]
283. Gabbrielli A, Pandolfi M, Mutignani M, et al. Efficacy of main pancreatic duct endoscopic drainage in patientas with chronic pancreatitis, continuous pain and dilated duct. Gastrointest Endosc 2005; 61: 576-81. [Crossref]
284. Eleftherladis N, Dinu F, Delhaye M, et al. Long-term outcome after pancreatic stenting in severe chronic pancreatitis. Endoscopy 2005; 37: 223-30. [Crossref]
285. Topazian M, Aslanian H, Andersen D. Outcome following endoscopic stenting of pancreatic duct strictures in chronic pancreatitis. J Clin Gastroenterol 2005; 39: 908-11. [Crossref]
286. Farnbacher MJ, Mühldorfer S, Wehler M, Fischer B, Hahn EG, Schneider HT. Interventional endoscopic therapy in chronic pancreatitis including temporary stenting: a definitive treatment? Scand J Gastroenterol 2006; 41: 111-7. [Crossref]
287. Ishihara T, Yamaguchi T, Seza K, Tadenuma H, Saisho H. Efficacy of s-type stents for the treatment of the main pancreatic duct stricture in patients with chronic pancreatitis. Scand J Gastroenterol 2006; 41: 744-50. [Crossref]
288. Sasahira N, Tada M, Isayama H, et al. Outcomes after clearance of pancreatic stones with or without pancreatic stenting. J Gastroenterol 2007; 42: 63-9. [Crossref]
289. Kim CH, Bang S, Song KH, et al. Analysis of the effects of stent insertion and the factors related to stent retrieval in chronic pancreatitis accompanying main pancreatic duct obstruction. Gut Liver 2007; 1: 63-7. [Crossref]
290. Hirota M, Asakura T, Kanno A, et al. Long-period pancreatic stenting for painful chronic calcified pancreatitis required higher medical costs and frequent hospitalizations compared with surgery. Pancreas 2011; 40: 946-50. [Crossref]
291. Clarke B, Slivka A, Tomizawa Y, et al. Endoscopic therapy is effective for patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2012; 10: 795-802. [Crossref]
292. Weber A, Schneider J, Neu B, et al. Endoscopic stent therapy in patients with chronic pancreatitis: A 5-year follow-up study. WJG 2013; 19: 715-20. [Crossref]
293. Tantau A, Mandrutiu A, Leucuta DC, Ciobanu L, Tantau M. Prognostic factors of response to endoscopic treatment in painful chronic pancreatitis. World J Gastroenterol 2017; 23: 6884-93. [Crossref]
294. Kawashima Y, Kawaguchi Y, Kawanishi A, et al. Comparison between endoscopic treatment and surgical drainage of the pancreatic duct in chronic pancreatitis. Tokai J Exp Clin Med 2018; 43: 117-21.
295. Farnbacher MJ, Radespiel-Tröger M, König MD, Wehler M, Hahn EG, Schneider HT. Pancreatic endoprostheses in chronic pancreatitis: criteria to predict stent occlusion. Gastrointest Endosc 2006; 63: 60-6. [Crossref]
296. ASGE Technology Assessment Committee, Pfau PR, Pleskow DK, et al. Pancreatic and biliary stents. Gastrointest Endosc 2013; 77: 319-27. [Crossref] 297. Costamagna G, Bulajic M, Tringali A, et al. Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: longterm results. Endoscopy 2006; 38: 254-9. [Crossref]
298. Eisendrath P, Deviere J. Expandable metal stents for benign pancreatic duct obstruction. Gastrointest Endosc Clin N Am 1999; 9: 547-54. [Crossref]
299. Okushima K, Yoshino J, Inui K, Miyoshi H, Nakamura Y. Short-term metal stenting for treatment of main pancreatic duct strictures associated with chronic pancreatitis. Digestive Endoscopy 2005; 17: 230-4. [Crossref]
300. Park do H, Kim MH, Moon SH, Lee SS, Seo DW, Lee SK. Feasibility and safety of placement of a newly designed, fully covered self-expandable metal stent for refractory benign pancreatic ductal strictures: a pilot study (with video). Gastrointest Endosc 2008; 68: 1182-9. [Crossref]
301. Sauer B, Talreja J, Ellen K, Ku J, Shami VM, Kahaleh M. Temporary placement of a fully covered self-expandable metal stent in the pancreatic duct for management of symptomatic refractory chronic pancreatitis: preliminary data (with videos). Gastrointest Endosc 2008; 68: 1173-8. [Crossref]
302. Moon SH, Kim MH, Park do H, et al. Modified fully covered self-expandable metal stents with antimigration features for benign pancreatic-duct strictures in advanced chronic pancreatitis, with a focus on the safety profile and reducing migration. Gastrointest Endosc 2010; 72: 86-91. [Crossref]
303. Giacino C, Grandval P, Laugier R. Fully covered selfexpanding metal stents for refractory pancreatic duct strictures in chronic pancreatitis. Endoscopy 2012; 44: 874-7. [Crossref]
304. Ogura T, Onda S, Takagi W, et al. Placement of a 6 mm, fully covered metal stent for main pancreatic head duct stricture due to chronic pancreatitis: a pilot study (with video). Therap Adv Gastroenterol 2016; 9: 722-8. [Crossref]
305. Matsubara S, Sasahira N, Isayama H. Prospective pilot study of fully covered self-expandable metal stents for refractory benign pancreatic duct strictures: long-term outcomes. Endosc Int Open 2016; 4: E1215-22. [Crossref]
306. Yamada T, Ogura T, Okuda A, et al. Pilot Study of Dumbbell-Type Covered Self expandable Metal Stent Deployment for Benign Pancreatic Duct Stricture (with Videos). J Gastrointest Surg 2018; 22: 2194-200. [Crossref]
307. Jeong IS, Lee SH, Oh SH, Park DH, Kim MK. Metal stents placement for refractory pancreatic duct stricture in children. World J Gastroenterol 2018; 24: 408-14. [Crossref]
308. Oh D, Lee JH, Song TJ, et al. Long-term outcomes of 6-mm diameter fully covered selfexpandable metal stents in benign refractory pancreatic ductal stricture. Digestive Endoscopy 2018; 30: 508-15. [Crossref]
309. Tringali A, Vadalà di Prampero SF, Landi R, et al. Fully covered self-expandable metal stents to dilate persistent pancreatic strictures in chronic pancreatitis: long-term follow-up from a prospective study. Gastrointest Endosc 2018; 88: 939-46. [Crossref]
310. Qin Z, Linghu EQ. Temporary placement of a fully covered self-expandable metal stent inthe pancreatic duct for aiding extraction of large pancreatic duct stones: preliminary data. Eur J Gastroenterol Hepatol 2014; 26: 1273-7. [Crossref]
311. Rimbas M, Larghi A. Endoscopic ultrasonography-guided techniques for accessing and draining the biliary system and the pancreatic duct. Gastrointest Endosc Clin N Am 2017; 27: 681-705. [Crossref]
312. Dhir V, Isayama H, Itoi T, et al. Endoscopic ultrasonography-guided biliary and pancreatic duct interventions. Dig Endosc 2017; 29: 472-85. [Crossref]
313. Harada N, Kouzu T, Arima M, Asano T, Kikuchi T, Isono K. Endoscopic ultrasound-guided pancreatography: a case report. Endoscopy 1995; 27: 612-5. [Crossref]
314. Wiersema MJ, Sandusky D, Carr R, Wiersema LM, Erdel WC, Frederick PK. Endosonography-guided cholangiopancreatography. Gastrointest Endosc 1996; 43: 102-6. [Crossref]
315. Gress F, Ikenberry S, Sherman S, Lehman G. Endoscopic ultrasound-directed pancreatography. Gastrointest Endosc 1996;44: 736-9. [Crossref]
316. Bataille L, Deprez P. A new application for therapeutic EUS: main pancreatic duct drainage with a ‘’pancreatic rendezvous technique.’’ Gastrointest Endosc 2002; 55: 740-3. [Crossref]
317. Francois E, Kahaleh M, Giovannini M, Matos C, Deviere J. EUS-guided pancreaticogastrostomy. Gastrointest Endosc 2002; 56: 128-33. [Crossref]
318. Kahaleh M, Yoshida C, Yeaton P. EUS antegrade pancreatography with gastropancreatic duct stent placement: review of two cases. Gastrointest Endosc 2003; 58: 919-23. [Crossref]
319. Mallery S, Matlock J, Freeman ML. EUS-guided rendezvous drainage of obstructed biliary and pancreatic ducts: report of 6 cases. Gastrointest Endosc 2004; 59: 100-7. [Crossref]
320. Will U, Meyer F, Manger T, Wanzar I. Endoscopic ultrasound-assisted rendezvous maneuver to achieve pancreatic duct drainage in obstructive chronic pancreatitis. Endoscopy 2005; 37: 171-3. [Crossref]
321. Mori N, Imazu H, Futagawa Y, et al. EUS-guided rendezvous drainage for pancreatic duct obstruction from stenosis of pancreatojejunal anastomosis after pancreatoduodenostomy. Surg Laparosc Endosc Percutan Tech 2012; 22: 236-8. [Crossref]
322. Gleeson FC, Pelaez MC, Petersen BT, Levy MJ. Drainage of an inaccessible main pancreatic duct via EUS-guided transgastric stenting through the minor papilla. Endoscopy 2007 Feb;39 Suppl 1: E313-4. [Crossref]
323. Das K, Kitano M, Komaki T, et al. Pancreatic ductal drainage by endoscopic ultrasound-assisted rendezvous technique for pain caused by ductal stricture with chronic pancreatitis. Dig Endosc 2010; 22: 217-9. [Crossref]
324. Onodera M, Kawakami H, Kuwatani M, et al. Endoscopic ultrasound-guided transmural drainage for pancreatic fistula or pancreatic duct dilation after pancreatic surgery. Surg Endosc 2012; 26: 1710-7. [Crossref]
325. Takikawa T, Kanno A, Masamune A, et al. Pancreatic duct drainage using EUS-guided rendezvous technique for stenotic pancreaticojejunostomy. World J Gastroenterol 2013; 19: 5182-6. [Crossref]
326. Hisa T, Momoi T, Shimizu T, Furutake M, Takamatsu M, Ohkubo H. Endoscopic ultrasound-guided antegrade stone removal in a patient with pancreatic stones and anastomotic stricture after end-to-side pancreaticojejunostomy. Pancreatology 2013; 13: 452-4. [Crossref]
327. Will U, Fueldner F, Thieme A, et al. Transgastric pancreatography and EUSguided drainage of the pancreatic duct. J Hepatobiliary Pancreat Surg 2007; 14: 377-82. [Crossref]
328. Kahaleh M, Hernandez AJ, Tokar J, Adams RB, Shami VM, Yeaton P. EUS-guided pancreaticogastrostomy: analysis of its efficacy to drain inaccessible pancreatic ducts. Gastrointest Endosc 2007; 65: 224-30. [Crossref]
329. Tessier G, Bories E, Arvanitakis M, et al. EUS-guided pancreatogastrostomy and pancreatobulbostomy for the treatment of pain in patients with pancreatic ductal dilatation inaccessible for transpapillary endoscopic therapy. Gastrointest Endosc 2007; 65: 233-41. [Crossref]
330. Ergun M, Aouattah T, Gillain C, Gigot JF, Hubert C, Deprez PH. Endoscopic ultrasound-guided transluminal drainage of pancreatic duct obstruction: long-term outcome. Endoscopy 2011; 43: 518-25. [Crossref]
331. Shah JN, Marson F, Weilert F, et al. Single-operator, single-session EUS-guided anterograde cholangiopancreatography in failed ERCP or inaccessible papilla. Gastrointest Endosc 2012; 75: 56-64.[Crossref]
332. Villa JJ, Pe’rez-Miranda M, Vazquez-Sequeiros E, et al. Initial experience with EUS-guided cholangiopancreatography for biliary and pancreatic duct drainage: a Spanish national survey. Gastrointest Endosc 2012; 76: 1133-41. [Crossref]
333. Kurihara T, Itoi T, Sofuni A, Itokawa F, Moriyasu F. Endoscopic ultrasonography-guided pancreatic duct drainage after failed endoscopic retrograde cholangiopancreatography in patients with malignant and benign pancreatic duct obstructions. Dig Endosc 2013; 25: 109-16. [Crossref]
334. Fujii LL, Topazian MD, Abu Dayyeh BK, et al. EUS-guided pancreatic duct intervention: outcomes of a single tertiary-care referral center experience. Gastrointest Endosc 2013; 78: 854-64.e1. [Crossref]
335. Will U, Reichel A, Fueldner F, Meyer F. Endoscopic ultrasonography-guided drainage for patients with symptomatic obstruction and enlargement of the pancreatic duct. World J Gastroenterol 2015; 21: 13140-51. [Crossref]
336. Oh D, Park do H, Cho MK, et al. Feasibility and safety of a fully covered selfexpandable metal stent with antimigration properties for EUS-guided pancreatic duct drainage: early and midterm outcomes (with video). Gastrointest Endosc 2016; 83: 366-73.e2. [Crossref]
337. Chen YI, Levy MJ, Moreels TG, et al. An international multicenter study comparing EUS-guided pancreatic duct drainage with enteroscopy-assisted endoscopic retrograde pancreatography after Whipple surgery. Gastrointest Endosc 2017; 85: 170-7. [Crossref]
338. Tyberg A, Sharaiha RZ, Kedia P, et al. EUS-guided pancreatic drainage for pancreatic strictures after failed ERCP: multicenter international collaborative study. Gastrointest Endosc 2017; 85: 164-9. [Crossref]
339. Adler DG, Lichtenstein D, Baron TH, et al. The role of endoscopy in patients with chronic pancreatitis. Gastrointest Endosc 2006; 63: 933-7. [Crossref]
340. Wyse JM, Sahai AV. Endoscopic Ultrasound-Guided Management of Pain in Chronic Pancreatitis and Pancreatic Cancer: an Update. Curr Treat Options Gastroenterol 2018; 16: 417-27. [Crossref]
341. Santosh D, Lakhtakia S, Gupta R, et al. Clinical trial: a randomized trial comparing fluoroscopy guided percutaneous technique vs. endoscopic ultrasound guided technique of coeliac plexus block for treatment of pain in chronic pancreatitis. Aliment Pharmacol Ther 2009; 29: 979-84. [Crossref]
342. Rana MV, Candido KD, Raja O, Knezevic NN. Celiac plexus block in the management of chronic abdominal pain. Curr Pain Headache Rep 2014; 18: 394. [Crossref]
343. Gress F, Schmitt C, Sherman S, Ikenberry S, Lehman G. A prospective randomized comparison of endoscopic ultrasound- and computed tomography-guided celiac plexus block for managing chronic pancreatitis pain. Am J Gastroenterol 1999; 94: 900-5. [Crossref]
344. Gress F, Schmitt C, Sherman S, Ciaccia D, Ikenberry S, Lehman G. Endocopic ultrasound guided celiac plexus block for managing abdominal pain associated with chronic pancreatitis: a prospective single center experience. Am J Gastroenterol 2001; 96: 409-16. [Crossref]
345. Sahai AV, Wyse J. EUS-guided celiac plexus block for chronic pancreatitis: a placebo-controlled trial should be the first priority. Gastrointest Endosc 2010; 71: 430-1. author reply 431. [Crossref]
346. Puli SR, Reddy JB, Bechtold ML, Antillon MR, Brugge WR. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci 2009; 54: 2330-7. [Crossref]
347. Kaufman M, Singh G, Das S, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol 2010; 44: 127-34. [Crossref]
348. Sey MS, Schmaltz L, Al-Haddad MA, et al. Effectiveness and safety of serial endoscopic ultrasound-guided celiac plexus block for chronic pancreatitis. Endosc Int Open 2015; 3: E56-9. [Crossref]
349. Levy MJ, Topazian MD, Wiersema MJ, et al. Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct Ganglia neurolysis and block. Am J Gastroenterol 2008; 103: 98-103. [Crossref]
350. Kappelle WFW, Bleys RLAW, van Wijck AJM, Siersema PD, Vleggaar FP. EUS-guided celiac ganglia neurolysis: a clinical and human cadaver study (with video). Gastrointest Endosc 2017; 86: 655-63. [Crossref]
351. Sahai AV, Lemelin V, Lam E, Paquin SC. Central vs. bilateral endoscopic ultrasound-guided celiac plexus block or neurolysis: a comparative study of short-term effectiveness. Am J Gastroenterol 2009; 104: 326-9. [Crossref]
352. LeBlanc JK, DeWitt J, Johnson C, et al. A prospective randomized trial of 1 versus 2 injections during EUS-guided celiac plexus block for chronic pancreatitis pain. Gastrointest Endosc 2009; 69: 835-42. [Crossref]
353. Leblanc JK, Al-Haddad M, McHenry L, et al. A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two? Gastrointest Endosc 2011; 74: 1300-7. [Crossref]
354. Gimeno-Garcia AZ, Elwassief A, Paquin SC, Sahai AV. Fatal complication after endoscopic ultrasound-guided celiac plexus neurolysis. Endoscopy 2012; 44: E267. [Crossref]
355. O’Toole TM, Schmulewitz N. Complication rates of EUS-guided celiac plexus blockade and neurolysis: results of a large case series. Endoscopy 2009; 41: 593-7. [Crossref]
356. Dua MM, Visser MC. Surgical approaches to chronic pancreatitis: Indications and techniques. Dig Dis Sci 2017; 62: 1738-44. [Crossref]
357. D’Haese JG, Ceyhan GO, Demir IE, Tieftrunk E, Friess H. Treatment Options in Painful Chronic Pancreatitis: A Systematic Review. HPB 2014; 16: 512-21. [Crossref]
358. Ahmed Ali U, Pahlplatz JM, Nealon WH, van Goor H, Gooszen HG, Boermeester MA. Endoscopic or surgical intervention for painful obstructive chronic pancreatitis. Cochrane Database Syst Rev 2015; (3): CD007884. [Crossref]
359. Ahmed Ali U, Nieuwenhuijs VB, van Eijck CH, et al. Clinical outcome in relation to timing of surgery in chronic pancreatitis: a nomogram to predict pain relief. Arch Surg 2012; 147: 925-32. [Crossref]
360. Yang CJ, Bliss LA, Freedman SD, et al. Surgery for chronic pancreatitis: the role of early surgery in pain management. Pancreas 2015; 44: 819-23. [Crossref]
361. Ke N, Jia D, Huang W, et al. Earlier surgery improves outcomes from painful chronic pancreatitis. Medicine (Baltimore) 2018; 97: e0651. [Crossref]
362. Ahmed Ali U, Issa Y, Bruno MJ, et al. Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): design and rationale of a randomized trial. BMC Gastroenterol 2013; 13: 49. [Crossref]
363. Jawad ZAR, Tsim N, Pai M, et al. Short and long-term post-operative outcomes of duodenum preserving pancreatic head resection for chronic pancreatitis affecting the head of pancreas: a systematic review and meta-analysis. HPB 2016; 18: 121-8. [Crossref]
364. Skube ME, Beilman GJ. Surgical treatment of pain in chronic pancreatitis. Curr Opin Gastroenterol 2018; 34: 1-5. [Crossref]
365. Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. HaPanEU/UEG Working Group. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) United European Gastroenterol J 2017; 5: 153-99. [Crossref]
366. Dominguez-Munoz JE, Iglesias-Garcia J. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: Is clinical response an appropriate marker for evaluation of therapeutic efficacy? J Pancreas 2010; 11: 158-62.
367. Regan PT, Malagelada JR, DiMagno EP, Glanzman SL, Go VL. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 1977; 297: 854-8. [Crossref]
368. Roberts KJ, Schrem H, Hodson J, et al. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. HPB (Oxford) 2017; 19: 859-67. [Crossref]
369. Layer P, Keller J, Lankisch PG. Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 2001; 3: 101-8. [Crossref]
370. Domínguez-Muñoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep 2007; 9: 116-22. [Crossref]
371. Sweetman S (ed). Martindale: The complete drug reference. 30th ed. London: Pharmaceutical Press, 1999.
372. Bruno MJ, Borm JJ, Hoek FJ, et al. Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis. Dig Dis Sci 1998; 43: 203-13. [Crossref]
373. Gelfond D, Ma C, Semler J, Borowitz D. Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule. Dig Dis Sci 2013; 58: 2275-81. [Crossref]
374. Dutta SK, Rubin J, Harvey J. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 1983; 84: 476-82. [Crossref]
375. Case CL, Henniges F, Barkin JS. Enzyme content and acid stability of enteric- coated pancreatic enzyme products in vitro. Pancreas 2005; 30: 180-3. [Crossref]
376. Kraisinger M, Hochhaus G, Stecenko A, Bowser E, Hendeles L. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations. J Clin Pharmacol 1994; 34: 158-66. [Crossref]
377. Halm U, Löser C, Löhr M, Katschinski M, Mössner J. A double blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrosphere versus microspheres in exocrine pancreatic insuffiency. Aliment Pharmacol Ther 1999; 13: 951-7. [Crossref]
378. Thorat V, Reddy N, Bhatia S, et al. Randomized clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis-a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2012; 36: 426-36. [Crossref]
379. Whitcomb DC, Lehman GA, Vasileva G, et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol 2010; 105: 2276-86. [Crossref]
380. Dominguez-Munoz JE, Iglesias-Garcia J, Iglesias-Rey M, Figueiras A, Vilarino-Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: A randomized, three-way crossover study. Aliment Pharmacol Ther 2005; 21: 993-1000. [Crossref]
381. O’Keefe SJ, Cariem AK, Levy M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J Clin Gastroenterol 2001; 32: 319-23. [Crossref]
382. Safdi M, Bekal PK, Martin S, Saeed ZA, Burton F, Toskes PP. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: A multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas 2006; 33: 156-62. [Crossref]
383. DiMagno EP, Malagelada JR, Go VL, Moertel CG. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med 1977; 296: 1318-22. [Crossref]
384. Czako L, Takacs T, Hegyi P, et al. Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis. Can J Gastroenterol 2003; 17: 597-603. [Crossref]
385. De la Iglesia-García D, Huang W, Szatmary P, et al. NIHR Pancreas Biomedical Research Unit Patient Advisory Group. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut 2017; 66: 1354-5. [Crossref]
386. Gubergrits N, Malecka-Panas E, Lehman GA, et al. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther 2011; 33: 1152-61. [Crossref]
387. Heubi JE, Schaeffer D, Ahrens RC, et al. Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiencydue to Cystic Fibrosis: A Randomized Controlled Clinical Trial. J Pediatr 2016; 176: 156-161.e1. [Crossref]
388. Domínguez-Muñoz JE, Nieto-Garcia L, López-Díaz J, Larino-Noia J, Abdulkader I, Iglesias-Garcia J. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. BMC Cancer 2018; 18: 534. [Crossref]
389. Ritz MA, Fraser RJ, Di Matteo AC, et al. Evaluation of the 13C-triolein breath test for fat malabsorption in adult patients with cystic fibrosis. J Gastroenterol Hepatol 2004; 19: 448-53. [Crossref]
390. Woestenenk JW, van der Ent CK, Houwen RH. Pancreatic enzyme replacement therapy and coefficient of fat absorption in children and adolescents with cystic fibrosis. J Pediatr Gastroenterol Nutr 2015; 61: 355-60. [Crossref]
391. Vecht J, Symersky T, Lamers CB, Masclee AM. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency. J Clin Gastroenterol 2006; 40: 721-5. [Crossref]
392. Proesmans M, De Boeck K. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes. Eur J Pediatr 2003; 162: 760-3. [Crossref]
393. Francisco MP, Wagner MH, Sherman JM, Theriaque D, Bowser E, Novak DA. Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002; 35: 79-83. [Crossref]
394. Sander-Struckmeier S, Beckmann K, Janssen-van Solingen G, Pollack P. Retrospective Analysis to Investigate the Effect of Concomitant Use of Gastric Acid Suppressing Drugs on the Efficacy and Safety of Pancrelipase/Pancreatin (CREON) in Patients with Pancreatic Exocrine Insufficiency. Pancreas 2013; 42: 983-9. [Crossref]
395. Etemad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682-707. [Crossref]
396. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32: 193-203. [Crossref]
397. Ali S, Fonseca V. Overview of metformin: special focus on metformin extended release. Expert Opin Pharmacother 2012; 13: 1797-805. [Crossref]
398. Ammann RW, Akovbiantz A, Largiader F, Schueller G. Course and outcome of chronic pancreatitis: Longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology 1984; 86: 820-8.
399. Hao L, Pan J, Wang D, Bi Y, Ji J, Xin L. Risk factors and nomogram for pancreatic pseudocysts in chronic pancreatitis: A cohort of 1998 patients. J Gastroenterol Hepatol 2017: 32: 1403-11. [Crossref]
400. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute Pancreatitis 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-11. [Crossref]
401. Markus ML, Stier A, Wahnschaffe U, Mayerle J. Pancreatic Pseudocysts Observation, Endoscopic Drainage, or Resection? Ann R Coll Surg Engl 2003; 85: 313-6.
402. Cheruvu CV, Clarke MG, Prentice M, Eyre-Brook IA. Conservative treatment as an option in the management of pancreatic pseudocyst. Ann R Coll Surg Engl 2003; 85: 313-6. [Crossref]
403. Rasch S, Nötzel B, Phillip V, Lahmer T, Schmid RM, Algül H. Management of pancreatic pseudocysts-A retrospective analysis. PLoS One 2017; 12: e0184374. [Crossref]
404. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta. Arch Surg 1993; 128: 586-90. [Crossref]
405. Zhao X, Feng T, Ji W. Endoscopic versus surgical treatment for pancreatic pseudocyst. Dig Endosc 2016; 28: 83-91. [Crossref]
406. Khreiss M, Zenati M, Clifford A, et al. Cyst Gastrostomy and Necrosectomy for the Management of Sterile Walled-Off Pancreatic Necrosis: a Comparison of Minimally Invasive Surgical and Endoscopic Outcomes at a High-Volume Pancreatic Center. J Gastrointest Surg 2015; 19: 1441-8. [Crossref]
407. Varadarajulu S, Bang JY, Sutton BS, Trevino JM, Christein JD, Wilcox CM. Equal efficacy of endoscopic and surgical cystogastrostomy for pancreatic pseudocyst drainage in a randomized trial. Gastroenterology 2013; 145: 583-90. [Crossref]
408. Varadarajulu S, Lopes TL, Wilcox CM, Drelichman ER, Kilgore ML, Christein JD. EUS versus surgical cyst-gastrostomy for management of pancreatic pseudocysts. Gastrointest Endosc 2008; 68: 649-55. [Crossref]
409. Keane MG, Sze SF, Cieplik N, et al. Endoscopic versus percutaneous drainage of symptomatic pancreatic fluid collections: a 14-year experience from a tertiary hepatobiliary centre. Surg Endosc 2016; 30: 3730-40. [Crossref]
410. Akshintala VS, Saxena P, Zaheer A, et al. A comparative evaluation of outcomes of endoscopic versus percutaneous drainage for symptomatic pancreatic pseudocysts. Gastrointest Endosc 2014; 79: 921-8. [Crossref]
411. Hollinghead W. The lower part of the common bile duct, a review. Surg Clin North Am 1957; 37: 939-52. [Crossref]
412. Eckhauser F, Knol J, Strodel W, Achem S, Nostrant T. Common bile duct strictures associated with chronic pancreatitis. Am Surg 1983; 49: 350-8.
413. Abdallah AA, Krige JEJ, Bornman PC. Biliary tract obstruction in chronic pancreatitis. HPB (Oxford) 2007; 9: 421-8. [Crossref]
414. Frey C, Suzuki M, Isaji S. Treatment of chronic pancreatitis by obstruction of the bile duct or duodenum. World J Surg 1990; 14: 59-69. [Crossref]
415. Devière J, Devaere S, Baize M, Cremer M. Endoscopic biliary drainage in chronic pancreatitis. Gastrointest Endosc 1990; 36: 96-100. [Crossref]
416. Smits ME, Rauws EA, van Gulik TM, Gouma DJ, Tytgat GN, Huibregtse K. Long-term results of endoscopic stenting and surgical drainage for biliary stricture due to chronic pancreatitis. Br J Surg 1996; 83: 764-8. [Crossref]
417. Vitale GC, Reed DN Jr, Nguyen CT, Lawhon JC, Larson GM. Endoscopic treatment of distal bile duct stricture from chronic pancreatitis. Surg Endosc 200; 14: 227-31. Erratum in: Surg Endosc 2000; 14: 411. [Crossref]
418. Farnbacher MJ, Rabenstein T, Ell C, Hahn EG, Schneider HT. Is endoscopic drainage of common bile duct stenoses in chronic pancreatitis up-to-date? Am J Gastroenterol 2000; 95: 1466-71. [Crossref]
419. Eickhoff A, Jakobs R, Leonhardt A, Eickhoff JC, Riemann JF. Endoscopic stenting for common bile duct stenoses in chronic pancreatitis: results and impact on long-term outcome. Eur J Gastroenterol Hepatol 2001; 13: 1161-7. [Crossref]
420. Kahl S, Zimmermann S, Genz I, et al. Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study. Am J Gastroenterol 2003; 98: 2448-53. [Crossref]
421. Catalano MF, Linder JD, George S, Alcocer E, Geenen JE. Treatment of symptomatic distal common bile duct stenosis secondary to chronic pancreatitis: comparison of single vs. multiple simultaneous stents. Gastrointest Endosc 2004; 60: 945-52. [Crossref]
422. Regimbeau JM, Fuks D, Bartoli E, et al. A comparative study of surgery and endoscopy for the treatment of bile duct stricture in patients with chronic pancreatitis. Surg Endosc 2012; 26: 2902-8. [Crossref]
423. Haapamäki C, Kylänpää L, Udd M, et al. Randomized multicenter study of multiple plastic stents vs. covered self-expandable metallic stent in the treatment of biliary stricture in chronic pancreatitis. Endoscopy 2015; 47: 605-10. [Crossref]
424. Draganov P, Hoffman B, Marsh W, Cotton P, Cunningham J. Long-term outcome in patients with benign biliary strictures treated endoscopically with multiple stents. Gastrointest Endosc 2002; 55: 680-6. [Crossref]
425. Pozsár J, Sahin P, László F, Forró G, Topa L. Medium-term results of endoscopic treatment of common bile duct strictures in chronic calcifying pancreatitis with increasing numbers of stents. J Clin Gastroenterol 2004; 38: 118-23. [Crossref]
426. Devière J, Nageshwar Reddy D, et al. Benign Biliary Stenoses Working Group. Successful management of benign biliary strictures with fully covered self-expanding metal stents. Gastroenterology 2014; 147: 385-95. [Crossref]
427. Cahen DL, van Berkel AM, Oskam D, et al. Long-term results of endoscopic drainage of common bile duct strictures in chronic pancreatitis. Eur J Gastroenterol Hepatol 2005; 17: 103-8.[Crossref]
428. Heider TR, Azeem S, Galanko JA, Behrns KE. The natural history of pancreatitis-induced splenic vein thrombosis. Ann Surg 2004; 239: 876-80. [Crossref]
429. Loftus JP, Nagorney DM, Ilstrup D, Kunselman AR. Sinistral portal hypertension. Splenectomy or expectant management. Ann Surg 1993; 217: 35-40. [Crossref]
430. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a longterm follow-up study in 568 portal hypertension patients. Hepatology 1992; 16: 1343-9. [Crossref]
431. Wani ZA, Bhat RA, Bhadoria AS, Maiwall R, Choudhury A. Gastric varices: classification, endoscopic and ultrasonographic management. J Res Med Sci 2015; 20: 1200-7. [Crossref]
432. Artifon ELA, Marson FP, Khan MA. Endoscopic ultrasonography-guided hemostasis techniques. Gastrointest Endosc Clin N Am 2017; 27: 741-7. [Crossref]
433. Al-Hillawi L, Wong T, Tritto G, Berry PA. Pitfalls in histoacryl glue injection therapy for oesophageal, gastric and ectopic varices: A review. World J Gastrointest Surg 2016; 8: 729-34. [Crossref]
434. Levy MJ, Wong Kee Song LM, Kendrick ML, Misra S, Gostout CJ. EUS-guided coil embolization for refractory ectopic variceal bleeding (with videos). Gastrointest Endosc 2008; 67: 572-4. [Crossref]
435. Romero-Castro R, Pellicer-Bautista F, Giovannini M, et al. Endoscopic ultrasound (EUS)-guided coil embolization therapy in gastric varices. Endoscopy 2010; 42 Suppl 2: E35-6. [Crossref]
436. Romero-Castro R, Ellrichmann M, Ortiz-Moyano C, et al. EUS-guided coil versus cyanoacrylate therapy for the treatment of gastric varices: a multicenter study (with videos). Gastrointest Endosc 2013; 78: 711-21. [Crossref]
437. Arakawa M, Masuzaki T, Okuda K. Pathology of fundic varices of the stomach and rupture. J Gastroenterol Hepatol 2002; 17: 1064-9. [Crossref]
438. Sakorafas GH, Sarr MG, Farley DR, Farnell MB. The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg 2000; 179: 129-33. [Crossref]
439. Agarwal AK, Raj Kumar K, Agarwal S, Singh S. Significance of splenic vein thrombosis in chronic pancreatitis. Am J Surg 2008; 196: 149-54. [Crossref]
440. Sathyamoorthy B, Sankareshwaran S, Vellaisamy R, et al. Need For Splenectomy in the Management of Asymptomatic Splenic Vein Thrombosis While Undergoing Surgery for Chronic Pancreatitis. J Pancreas (Online) 2017; 18: 12-8.
441. Rebours V, Boudaoud L, Vullierme MP, et al. Extrahepatic portal venous system thrombosis in recurrent acute and chronic alcoholic pancreatitis is caused by local inflammation and not thrombophilia. Am J Gastroenterol 2012; 107: 1579-85. [Crossref]
442. Harris S, Naina H, Chari S, et al. Does anticoagulation for venous thromboembolism in acute pancreatitis result in pancreatic and/or peri-pancreatic bleeding? Gastroenterology 2008; 134: 4: A-375. [Crossref]
443. Pribramska V, Vege S, Trna J, et al. Natural history of splanchnic venous thrombosis in acute pancreatitis: a population-based study. Gastroenterology 2009; 136: 5: A-541. [Crossref]
444. Harris S, Nadkarni NA, Naina HV, Vege SS. Splanchnic vein thrombosis in acute pancreatitis: a single-center experience. Pancreas 2013; 42: 1251-4. [Crossref]
445. Pang TC, Maher R, Gananadha S, Hugh TJ, Samra JS. Peripancreatic pseudoaneurysms: a management-based classification system. Surg Endosc 2014; 28: 2027-38. [Crossref]
446. De Perrot M, Buhler L, Schneider PA, Mentha G, Morel P. Do aneurysms and pseudoaneurysms of the splenic artery require different surgical strategy? Hepatogastroenterology. 1999; 46: 2028-32.
447. Udd M, Leppäniemi AK, Bidel S, Keto P, Roth WD, Haapiainen RK. Treatment of bleeding pseudoaneurysms in patients with chronic pancreatitis. World J Surg 2007; 31: 504-10. [Crossref]
448. Verde F, Fishman EK, Johnson PT. Arterial pseudoaneurysms complicating pancreatitis: literature review. J Comput Assist Tomogr 2015; 39: 7-12. [Crossref]
449. Roach H, Roberts SA, Salter R, Williams IM, Wood AM. Endoscopic ultrasound-guided thrombin injection for the treatment of pancreatic pseudoaneurysm. Endoscopy 2005; 37: 876-8. [Crossref]
450. Jeffers K, Majumder S, Vege SS, Levy M. EUS-guided pancreatic pseudoaneurysm therapy: better to be lucky than good. Gastrointest Endosc 2018; 87: 1155-6. [Crossref]
451. Jhajharia A, Wanjari S, Ashdhir P, Sharma D, Pokharna R, Nijhawan S. Endoscopic ultrasound-guided thrombin injection for management of visceral artery pseudoaneurysm: A novel approach. Indian J Gastroenterol 2018; 37: 271-5. [Crossref]
452. Rai P, Kc H, Goel A, Aggarwal R, Sharma M. Endoscopic ultrasound-guided coil and glue for treatment of splenic artery pseudo-aneurysm: new kid on the block! Endosc Int Open 2018; 6: E821-5. [Crossref]
453. Bergert H, Dobrowolski F, Caffier S, Bloomenthal A, Hinterseher I, Saeger HD. Prevalence and treatment of bleeding complications in chronic pancreatitis. Langenbecks Arch Surg 2004; 389: 504-10. [Crossref]
454. Zhang P, Li H, Tan X, Chen L, Wang S. Association of metformin use with cancer incidence and mortality: a meta-analysis. Cancer Epidemiol 2013; 37: 207-18. [Crossref]
455. Ambe CM, Mahipal A, Fulp J, Chen L, Malafa MP. Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature. PLoS One 2016; 11: e0151632. [Crossref]
456. Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 2009; 32: 1620-5. [Crossref]
457. Zhou PT, Li B, Liu FR, et al. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Oncotarget 2017; 8: 25242-50. [Crossref]
458. Gong J, Robbins LA, Lugea A, Waldron RT, Jeon CY, Pandol SJ. Diabetes, pancreatic cancer, and metformin therapy. Front Physiol 2014; 5: 426. [Crossref]
459. Chen K, Qian W, Jiang Z, et al. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. Molecular Cancer 2017; 16: 131. [Crossref]
460. Salvatore Salvatore T, Marfella R, Rizzo MR, Sasso FC. Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist. Int J Surg 2015; 21 Suppl 1: 72-7. [Crossref]
461. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871-7. [Crossref]
462. Dong YW, Shi YQ, He LW, Cui XY, Su PZ. Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis. Oncotarget 2017; 8: 55478-88. [Crossref]
463. Wan G, Sun X, Li F, et al. Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis. Cell Physiol Biochem 2018; 49: 837-47. [Crossref]
464. Jian-Yu E, Graber JM, Lu SE, Lin Y, Lu-Yao G, Tan XL. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis. Curr Med Chem 2018; 25: 2595-607. [Crossref]
465. Zhang JW, Sun Q. Metformin may improve the prognosis of patients with pancreatic cancer. Asian Pac J Cancer Prev 2015; 16: 3937-40. [Crossref]
466. Wang Z, Lai ST, Xie L, et al. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract 2014; 106: 19-26. [Crossref]
467. Ruiter R, Visser LE, van Herk-Sukel MP, et al. Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study. Diabetes Care 2012; 35: 119-24. [Crossref]
468. Decensi A, Puntoni M, Goodwin P, et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2010; 3: 1451-61. [Crossref]
469. Singh S, Singh PP, Singh AG, Murad MH, McWilliams RR, Chari ST. Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 510-9. [Crossref]
470. Beyer G, Mahajan UM, Budde C, et al. Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent Cohorts. Gastroenterology 2017; 153: 1544-54.e2. [Crossref]
471. Bang UC, Benfield T, Hyldstrup L, Bendtsen F, Beck Jensen JE. Mortality, cancer, and comorbidities associated with chronic pancreatitis: a Danish nationwide matched-cohort study. Gastroenterology 2014; 146: 989-94. [Crossref]
472. Lew D, Afghani E, Pandol S. Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment. Dig Dis Sci 2017; 62: 1702-12. [Crossref]
473. Ahmed Ali U, Issa Y, van Goor H, et al. Dutch Pancreatitis Study Group. Dutch Chronic Pancreatitis Registry (CARE): design and rationale of a nationwide prospective evaluation and follow-up. Pancreatology 2015; 15: 46-52. [Crossref]
474. Xiao AY, Tan ML, Wu LM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol 2016; 1: 45-55. [Crossref]
475. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group. Am J Gastroenterol 1994; 89: 1467-71.
476. Whitcomb DC, Preston RA, Aston CE, et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 1996; 110: 1975-80. [Crossref]
477. Alsamarrai A, Das SL, Windsor JA, Petrov MS. Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2014; 12: 1635-44.e5; quiz e103. [Crossref]

APA	SOYTÜRK M, BENGİ G, OĞUZ D, KALKAN İ, YALNIZ M, TAHTACI M, Demir K, KASAP E, ORUÇ N, ÜNAL N, Sezgin O, Ozdogan O, ALTINTAS E, YARAŞ S, PARLAK E, KÖKSAL A, Saruç M, ÜNAL H, Ünsal B, Gunay S, DUMAN D, YURÇİ A, KAÇAR S, Filik L (2020). Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report. , 1 - 41. 10.5152/tjg.2020.220920
Chicago	SOYTÜRK Müjde,BENGİ Göksel,OĞUZ Dilek,KALKAN İsmail Hakkı,YALNIZ Mehmet,TAHTACI Mustafa,Demir Kadir,KASAP Elmas,ORUÇ Nevin,ÜNAL Nalan Gülşen,Sezgin Orhan,Ozdogan Osman,ALTINTAS ENGIN,YARAŞ Serkan,PARLAK Erkan,KÖKSAL Aydın Şeref,Saruç Murat,ÜNAL Hakan,Ünsal Belkıs,Gunay Suleyman,DUMAN Deniz,YURÇİ Alper,KAÇAR Sabite,Filik Levent Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report. (2020): 1 - 41. 10.5152/tjg.2020.220920
MLA	SOYTÜRK Müjde,BENGİ Göksel,OĞUZ Dilek,KALKAN İsmail Hakkı,YALNIZ Mehmet,TAHTACI Mustafa,Demir Kadir,KASAP Elmas,ORUÇ Nevin,ÜNAL Nalan Gülşen,Sezgin Orhan,Ozdogan Osman,ALTINTAS ENGIN,YARAŞ Serkan,PARLAK Erkan,KÖKSAL Aydın Şeref,Saruç Murat,ÜNAL Hakan,Ünsal Belkıs,Gunay Suleyman,DUMAN Deniz,YURÇİ Alper,KAÇAR Sabite,Filik Levent Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report. , 2020, ss.1 - 41. 10.5152/tjg.2020.220920
AMA	SOYTÜRK M,BENGİ G,OĞUZ D,KALKAN İ,YALNIZ M,TAHTACI M,Demir K,KASAP E,ORUÇ N,ÜNAL N,Sezgin O,Ozdogan O,ALTINTAS E,YARAŞ S,PARLAK E,KÖKSAL A,Saruç M,ÜNAL H,Ünsal B,Gunay S,DUMAN D,YURÇİ A,KAÇAR S,Filik L Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report. . 2020; 1 - 41. 10.5152/tjg.2020.220920
Vancouver	SOYTÜRK M,BENGİ G,OĞUZ D,KALKAN İ,YALNIZ M,TAHTACI M,Demir K,KASAP E,ORUÇ N,ÜNAL N,Sezgin O,Ozdogan O,ALTINTAS E,YARAŞ S,PARLAK E,KÖKSAL A,Saruç M,ÜNAL H,Ünsal B,Gunay S,DUMAN D,YURÇİ A,KAÇAR S,Filik L Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report. . 2020; 1 - 41. 10.5152/tjg.2020.220920
IEEE	SOYTÜRK M,BENGİ G,OĞUZ D,KALKAN İ,YALNIZ M,TAHTACI M,Demir K,KASAP E,ORUÇ N,ÜNAL N,Sezgin O,Ozdogan O,ALTINTAS E,YARAŞ S,PARLAK E,KÖKSAL A,Saruç M,ÜNAL H,Ünsal B,Gunay S,DUMAN D,YURÇİ A,KAÇAR S,Filik L "Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report." , ss.1 - 41, 2020. 10.5152/tjg.2020.220920
ISNAD	SOYTÜRK, Müjde vd. "Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report". (2020), 1-41. https://doi.org/10.5152/tjg.2020.220920

APA	SOYTÜRK M, BENGİ G, OĞUZ D, KALKAN İ, YALNIZ M, TAHTACI M, Demir K, KASAP E, ORUÇ N, ÜNAL N, Sezgin O, Ozdogan O, ALTINTAS E, YARAŞ S, PARLAK E, KÖKSAL A, Saruç M, ÜNAL H, Ünsal B, Gunay S, DUMAN D, YURÇİ A, KAÇAR S, Filik L (2020). Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report. Turkish Journal of Gastroenterology, 31(Supplement 1), 1 - 41. 10.5152/tjg.2020.220920
Chicago	SOYTÜRK Müjde,BENGİ Göksel,OĞUZ Dilek,KALKAN İsmail Hakkı,YALNIZ Mehmet,TAHTACI Mustafa,Demir Kadir,KASAP Elmas,ORUÇ Nevin,ÜNAL Nalan Gülşen,Sezgin Orhan,Ozdogan Osman,ALTINTAS ENGIN,YARAŞ Serkan,PARLAK Erkan,KÖKSAL Aydın Şeref,Saruç Murat,ÜNAL Hakan,Ünsal Belkıs,Gunay Suleyman,DUMAN Deniz,YURÇİ Alper,KAÇAR Sabite,Filik Levent Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report. Turkish Journal of Gastroenterology 31, no.Supplement 1 (2020): 1 - 41. 10.5152/tjg.2020.220920
MLA	SOYTÜRK Müjde,BENGİ Göksel,OĞUZ Dilek,KALKAN İsmail Hakkı,YALNIZ Mehmet,TAHTACI Mustafa,Demir Kadir,KASAP Elmas,ORUÇ Nevin,ÜNAL Nalan Gülşen,Sezgin Orhan,Ozdogan Osman,ALTINTAS ENGIN,YARAŞ Serkan,PARLAK Erkan,KÖKSAL Aydın Şeref,Saruç Murat,ÜNAL Hakan,Ünsal Belkıs,Gunay Suleyman,DUMAN Deniz,YURÇİ Alper,KAÇAR Sabite,Filik Levent Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report. Turkish Journal of Gastroenterology, vol.31, no.Supplement 1, 2020, ss.1 - 41. 10.5152/tjg.2020.220920
AMA	SOYTÜRK M,BENGİ G,OĞUZ D,KALKAN İ,YALNIZ M,TAHTACI M,Demir K,KASAP E,ORUÇ N,ÜNAL N,Sezgin O,Ozdogan O,ALTINTAS E,YARAŞ S,PARLAK E,KÖKSAL A,Saruç M,ÜNAL H,Ünsal B,Gunay S,DUMAN D,YURÇİ A,KAÇAR S,Filik L Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report. Turkish Journal of Gastroenterology. 2020; 31(Supplement 1): 1 - 41. 10.5152/tjg.2020.220920
Vancouver	SOYTÜRK M,BENGİ G,OĞUZ D,KALKAN İ,YALNIZ M,TAHTACI M,Demir K,KASAP E,ORUÇ N,ÜNAL N,Sezgin O,Ozdogan O,ALTINTAS E,YARAŞ S,PARLAK E,KÖKSAL A,Saruç M,ÜNAL H,Ünsal B,Gunay S,DUMAN D,YURÇİ A,KAÇAR S,Filik L Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report. Turkish Journal of Gastroenterology. 2020; 31(Supplement 1): 1 - 41. 10.5152/tjg.2020.220920
IEEE	SOYTÜRK M,BENGİ G,OĞUZ D,KALKAN İ,YALNIZ M,TAHTACI M,Demir K,KASAP E,ORUÇ N,ÜNAL N,Sezgin O,Ozdogan O,ALTINTAS E,YARAŞ S,PARLAK E,KÖKSAL A,Saruç M,ÜNAL H,Ünsal B,Gunay S,DUMAN D,YURÇİ A,KAÇAR S,Filik L "Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report." Turkish Journal of Gastroenterology, 31, ss.1 - 41, 2020. 10.5152/tjg.2020.220920
ISNAD	SOYTÜRK, Müjde vd. "Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report". Turkish Journal of Gastroenterology 31/Supplement 1 (2020), 1-41. https://doi.org/10.5152/tjg.2020.220920